Any antiviral agent which inhibits the activity of coronaviruses.
| Member | Definition | Class |
|---|
| (4-Ethyl-2-oxochromen-7-yl) furan-2-carboxylate | | (4-Ethyl-2-oxochromen-7-yl) furan-2-carboxylate |
| (4-Methoxyphenyl)-(2-methylsulfanyl-6,7-dihydro-[1,4]dioxino[2,3-f]benzimidazol-3-yl)methanone | | (4-Methoxyphenyl)-(2-methylsulfanyl-6,7-dihydro-[1,4]dioxino[2,3-f]benzimidazol-3-yl)methanone |
| (4-Methyl-2-oxochromen-7-yl) furan-2-carboxylate | | (4-Methyl-2-oxochromen-7-yl) furan-2-carboxylate |
| (5-Chloropyridin-3-yl) 1H-indole-4-carboxylate | | (5-Chloropyridin-3-yl) 1H-indole-4-carboxylate |
| (5-Chloropyridin-3-yl) 1H-indole-5-carboxylate | | (5-Chloropyridin-3-yl) 1H-indole-5-carboxylate |
| (E)-4-Phenyl-2-(3-(thiophen-2-yl)acrylamido)thiophene-3-carboxylic acid | | (E)-4-Phenyl-2-(3-(thiophen-2-yl)acrylamido)thiophene-3-carboxylic acid |
| 1-(2-Naphthylmethyl)-2,3-dioxo-indoline-5-carboxamide | | 1-(2-Naphthylmethyl)-2,3-dioxo-indoline-5-carboxamide |
| 1-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-5-ethoxy-isatin | | 1-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-5-ethoxy-isatin |
| 1-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-5-methoxy-isatin | | 1-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-5-methoxy-isatin |
| 1-(Chloroacetyl)-3-(1H-indol-3-yl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-4-ol | | 1-(Chloroacetyl)-3-(1H-indol-3-yl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-4-ol |
| 1-(Chloroacetyl)-5-[4-(difluoromethoxy)-3-methoxyphenyl]-3-thien-2-yl-4,5-dihydro-1H-pyrazole | | 1-(Chloroacetyl)-5-[4-(difluoromethoxy)-3-methoxyphenyl]-3-thien-2-yl-4,5-dihydro-1H-pyrazole |
| 1-(N-[2-(Benzotriazol-1-yl)acetyl]-4-methoxyanilino)-N-cyclopentylcyclohexane-1-carboxamide | | 1-(N-[2-(Benzotriazol-1-yl)acetyl]-4-methoxyanilino)-N-cyclopentylcyclohexane-1-carboxamide |
| 1-Benzyl-3-pyridin-3-yl-1H-pyrazole-4-carbaldehyde | | 1-Benzyl-3-pyridin-3-yl-1H-pyrazole-4-carbaldehyde |
| 2-(1H-1,2,3-Benzotriazol-1-yl)-N'-(3,4,5-trimethoxybenzylidene)acetohydrazide | | 2-(1H-1,2,3-Benzotriazol-1-yl)-N'-(3,4,5-trimethoxybenzylidene)acetohydrazide |
| 2-(3-Amino-3-oxopropyl)-3-(4-chlorobenzoyl)-2H-indazole 1-oxide | | 2-(3-Amino-3-oxopropyl)-3-(4-chlorobenzoyl)-2H-indazole 1-oxide |
| 2-(3-Amino-3-oxopropyl)-3-(4-methylbenzoyl)-2H-indazole 1-oxide | | 2-(3-Amino-3-oxopropyl)-3-(4-methylbenzoyl)-2H-indazole 1-oxide |
| 2-(Benzotriazol-1-yl)-1-(4-bromophenyl)ethanone | | 2-(Benzotriazol-1-yl)-1-(4-bromophenyl)ethanone |
| 2-(Chloroacetyl)-N,2-diphenylhydrazinecarboxamide | | 2-(Chloroacetyl)-N,2-diphenylhydrazinecarboxamide |
| 2-(N-[2-(Benzotriazol-1-yl)acetyl]-2,4,6-trimethylanilino)-N-tert-butyl-2-thiophen-3-ylacetamide | | 2-(N-[2-(Benzotriazol-1-yl)acetyl]-2,4,6-trimethylanilino)-N-tert-butyl-2-thiophen-3-ylacetamide |
| 2-Chloro-1-[2,5-dimethyl-1-(3-nitrophenyl)-1H-pyrrol-3-yl]ethan-1-one | | 2-Chloro-1-[2,5-dimethyl-1-(3-nitrophenyl)-1H-pyrrol-3-yl]ethan-1-one |
| 2-Chloro-1-[3-(4-methylphenyl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]ethanone | | 2-Chloro-1-[3-(4-methylphenyl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]ethanone |
| 2-Chloro-1-[5-(3,4-dimethoxyphenyl)-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one | | 2-Chloro-1-[5-(3,4-dimethoxyphenyl)-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one |
| 2-Chloro-1-[5-(furan-2-yl)-3-(5-methylfuran-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one | | 2-Chloro-1-[5-(furan-2-yl)-3-(5-methylfuran-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one |
| 3-(4-Amino-3,5-dichlorobenzoyl)-2-(3-amino-3-oxopropyl)-2H-indazole 1-oxide | | 3-(4-Amino-3,5-dichlorobenzoyl)-2-(3-amino-3-oxopropyl)-2H-indazole 1-oxide |
| 3-fluoro-Nalpha-(1H-indol-2-ylcarbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide | A secondary carboxamide resulting from the formal condensation of the carboxy group of 1H-indole-2-carboxylic acid with the primary amino group of 3-fluoro-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide. It is an inhibitor of SARS coronavirus main proteinase and inhibits SARS-CoV-2 replication in cell culture (EC50 = 0.72 muM). | 3-fluoro-Nalpha-(1H-indol-2-ylcarbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide |
| 4-[4-(2,3-Dimethylphenyl)piperazine-1-carbonyl]-1H-quinolin-2-one | | 4-[4-(2,3-Dimethylphenyl)piperazine-1-carbonyl]-1H-quinolin-2-one |
| 4-[4-(2,3,5,6-Tetramethylphenyl)sulfonylpiperazine-1-carbonyl]-1H-quinolin-2-one | | 4-[4-(2,3,5,6-Tetramethylphenyl)sulfonylpiperazine-1-carbonyl]-1H-quinolin-2-one |
| 4-[4-[3-(Trifluoromethyl)phenyl]piperazine-1-carbonyl]-1H-quinolin-2-one | | 4-[4-[3-(Trifluoromethyl)phenyl]piperazine-1-carbonyl]-1H-quinolin-2-one |
| 4-Chloro-2-(5-methyl-1,3-dioxooctahydro-2H-isoindol-2-yl)phenyl 2-furoate | | 4-Chloro-2-(5-methyl-1,3-dioxooctahydro-2H-isoindol-2-yl)phenyl 2-furoate |
| 5-(4-Chloro-benzenesulfonyl)-pyrimidine-2,4-diamine | | 5-(4-Chloro-benzenesulfonyl)-pyrimidine-2,4-diamine |
| 5-bromoisatin | | 5-Bromoisatin |
| 5-Bromopyridin-3-yl furan-2-carboxylate | | 5-Bromopyridin-3-yl furan-2-carboxylate |
| 5-Chloro-1H-indole-2,3-dione | | 5-Chloro-1H-indole-2,3-dione |
| 5-Chloro-3-pyridinyl 2-furoate | | 5-Chloro-3-pyridinyl 2-furoate |
| 5-Chloropyridin-3-yl 1H-indole-2-carboxylate | | 5-Chloropyridin-3-yl 1H-indole-2-carboxylate |
| 5-Chloropyridin-3-yl 5-(4-chlorophenyl)furan-2-carboxylate | | 5-Chloropyridin-3-yl 5-(4-chlorophenyl)furan-2-carboxylate |
| 5-Fluoroisatin | | 5-Fluoroisatin |
| 5-iodoisatin | | 5-Iodoisatin |
| 5-Methoxyisatin | | 5-Methoxyisatin |
| 5-Nitroisatin | | 5-Nitroisatin |
| 6-methoxy-3-nitro-2-(phenylsulfonyl)pyridine | | 2-(Benzenesulfonyl)-6-methoxy-3-nitropyridine |
| 8-(Trifluoromethyl)-9H-purin-6-amine | | 8-(Trifluoromethyl)-9H-purin-6-amine |
| alisporivir | | Alisporivir |
| aloxistatin | An L-leucine derivative that is the amide obtained by formal condensation of the carboxy group of (2S,3S)-3-(ethoxycarbonyl)oxirane-2-carboxylic acid with the amino group of N-(3-methylbutyl)-L-leucinamide. | aloxistatin |
| amodiaquine | A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position. | amodiaquine |
| amodiaquine hydrochloride | | amodiaquine hydrochloride |
| anacardic acid | A hydroxybenzoic acid that is salicylic acid substituted by a pentadecyl group at position 6. It is a major component of cashew nut shell liquid and exhibits an extensive range of bioactivities. | anacardic acid |
| anisomycin | An antibiotic isolated from various Streptomyces species. It interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system. | (-)-anisomycin |
| astemizole | A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position. | astemizole |
| azd 6244 | A member of the class of benzimidazoles that is 1-methyl-1H-benzimidazole which is substituted at positions 4, 5, and 6 by fluorine, (4-bromo-2-chlorophenyl)amino, and N-(2-hydroxyethoxy)aminocarbonyl groups, respectively. It is a MEK1 and MEK2 inhibitor. | selumetinib |
| baicalein | A trihydroxyflavone with the hydroxy groups at positions C-5, -6 and -7. | baicalein |
| baicalin | The glycosyloxyflavone which is the 7-O-glucuronide of baicalein. It is an active ingredient of Chinese herbal medicine Scutellaria baicalensis. | baicalin |
| Benzotriazol-1-yl 1H-indole-5-carboxylate | | Benzotriazol-1-yl 1H-indole-5-carboxylate |
| Benzyl N-[(2S)-3-methyl-1-[[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]-1-(1,3-thiazol-2-yl)propan-2-yl]amino]pentan-2-yl]amino]-1-oxobutan-2-yl]carbamate | | Benzyl N-[(2S)-3-methyl-1-[[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]-1-(1,3-thiazol-2-yl)propan-2-yl]amino]pentan-2-yl]amino]-1-oxobutan-2-yl]carbamate |
| betulonic acid | | Betulonic acid |
| brequinar | A quinolinemonocarboxylic acid that is quinoline substituted by 2'-fluoro[1,1'-biphenyl]-4-yl, methyl, carboxy and fluoro groups at positions 2, 3, 4, and 6, respectively. It is an inhibitor of dihydroorotate dehydrogenase, an enzyme that is required for de novo pyrimidine biosynthesis. The compound exhibits antineoplastic and antiviral properties. | brequinar |
| brequinar sodium | An organic sodium salt of brequinar. | brequinar sodium |
| camostat | A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients. | camostat |
| camostat mesylate | A methanesulfonate (mesylate) salt prepared from equimolar amounts of camostat and methanesulfonic acid. It is a serine protease inhibitor approved and marketed in Japan in 1985 for the alleviation of acute symptoms associated with chronic pancreatitis. In 1994, it was approved for the treatment of postoperative reflux esophagitis. | camostat mesylate |
| chloroquine | An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis. | chloroquine |
| chlorphenoxamine | | chlorphenoxamine |
| chlorpromazine | A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety. | chlorpromazine |
| chlorpromazine hydrochloride | The hydrochloride salt of chlorpromazine. | chlorpromazine hydrochloride |
| CID 2131972 | | CID 2131972 |
| CID 3191469 | | CID 3191469 |
| CID 3192987 | | CID 3192987 |
| CID 3198732 | | CID 3198732 |
| CID 3206295 | | CID 3206295 |
| cinanserin | An aryl sulfide that is (2E)-3-phenyl-N-(2-sulfanylphenyl)prop-2-enamide in which the hydrogen of the thiol group is substituted by a 3-(dimethylamino)propyl group. It is a 5-hydroxytryptamine receptor antagonist and an inhibitor of SARS-CoV replication. | cinanserin |
| clomipramine | A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias. | clomipramine |
| clomipramine hydrochloride | A hydrochloride resulting from the reaction of equimolar amounts of clomipramine and hydrogen chloride. One of the more sedating tricyclic antidepressants, it is used for the treatment of depression as well as obsessive-compulsive disorder and phobias. | clomipramine hydrochloride |
| cryptotanshinone | | Cryptotanshinone |
| cycloheximide | A dicarboximide that is 4-(2-hydroxyethyl)piperidine-2,6-dione in which one of the hydrogens attached to the carbon bearing the hydroxy group is replaced by a 3,5-dimethyl-2-oxocyclohexyl group. It is an antibiotic produced by the bacterium Streptomyces griseus. | cycloheximide |
| cyclosporine | A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle. | cyclosporin A |
| dabrafenib | An organofluorine compound and antineoplastic agent, used as its mesylate salt in treatment of metastatic melanoma. | dabrafenib |
| dasatinib | An aminopyrimidine that is 2-methylpyrimidine which is substituted at position 4 by the primary amino group of 2-amino-1,3-thiazole-5-carboxylic acid and at position 6 by a 4-(2-hydroxyethyl)piperazin-1-yl group, and in which the carboxylic acid group has been formally condensed with 2-chloro-6-methylaniline to afford the corresponding amide. A multi-targeted kinase inhibitor, it is used, particularly as the monohydrate, for the treatment of chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia. Note that the name 'dasatinib' is used to refer to the monohydrate (USAN) as well as to anhydrous dasatinib (INN). | dasatinib (anhydrous) |
| Dihydrotanshinone I | | Dihydrotanshinone I |
| ebselen | A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase. | ebselen |
| emetine | A pyridoisoquinoline comprising emetam having methoxy substituents at the 6'-, 7'-, 10- and 11-positions. It is an antiprotozoal agent and emetic. It inhibits SARS-CoV2, Zika and Ebola virus replication and displays antimalarial, antineoplastic and antiamoebic properties. | emetine |
| emetine dihydrochloride | The dihydrochloride salt of emetine. | emetine dihydrochloride |
| Ethyl (E,4S)-4-[[(2S)-2-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-3-phenylpropanoyl]amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate | | Ethyl (E,4S)-4-[[(2S)-2-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-3-phenylpropanoyl]amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate |
| ethylmaleimide | A member of the class of maleimides that is the N-ethyl derivative of maleimide. | N-ethylmaleimide |
| everolimus | A macrocyclic lactone that is rapamycin in which the hydroxy group attached to the cyclohexyl moiety has been converted into the corresponding 2-hydroxyethyl ether. It is an immunosuppressant and antineoplastic agent. | everolimus |
| favipiravir | A member of the class of pyrazines that is pyrazine substituted by aminocarbonyl, hydroxy and fluoro groups at positions 2, 3 and 6, respectively. It is an anti-viral agent that inhibits RNA-dependent RNA polymerase of several RNA viruses and is approved for the treatment of influenza in Japan. | favipiravir |
| fluphenazine | A member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position. | fluphenazine |
| fluphenazine hydrochloride | | Fluphenazine hydrochloride |
| gemcitabine hydrochloride | A 2'-deoxycytidine hydrochloriode having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine hydrochloride is used in the treatment of various carcinomas, including non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer. | gemcitabine hydrochloride |
| GRL-0617 | A benzamide resulting from the formal condensation of the carboxy group of 5-amino-2-methylbenzoic acid with the amino group of (1R)-1-(naphthalen-1-yl)ethan-1-amine. It is a potent noncovalent inhibitor (IC50 = 600 nM) of severe acute respiratory syndrome-coronavirus papain-like protease (SARS-CoV PLpro). | GRL-0617 |
| GS-441524 | A C-nucleoside analog that is (2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile substituted by a 4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl group at position 2. It is the active metabolite of remdesivir and exhibits a broad range of inhibitory activity against various RNA viruses including HCV, parainfluenza and SARS-CoV. | GS-441524 |
| GS-443902 | An organic triphosphate that is GS-441524 in which the 5'-hydroxy group has been replaced by a triphosphate group. It is the active metabolite of remdesivir. | GS-443902 |
| gsk 2126458 | A member of the class of quinolines that is quinoline which is substituted by pyridazin-4-yl and 5-[(2,4-difluorobenzene-1-sulfonyl)amino]-6-methoxypyridin-3-yl groups at positions 4 and 6, respectively. It is a highly potent inhibitor of PI3K and mTOR developed by GlaxoSmithKline and was previously in human phase 1 clinical trials for the treatment of idiopathic pulmonary fibrosis and solid tumors. | omipalisib |
| homoharringtonine | A cephalotaxine-derived alkaloid ester obtained from Cephalotaxus harringtonia; used for the treatment of chronic or accelerated phase chronic myeloid leukaemia. | omacetaxine mepesuccinate |
| hydroxychloroquine | An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions. | hydroxychloroquine |
| hydroxyzine | A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively. | hydroxyzine |
| imatinib mesylate | A methanesulfonate (mesylate) salt that is the monomesylate salt of imatinib. Used for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours. | imatinib methanesulfonate |
| KOM70144 | A benzamide that is GRL-0617 in which one of the hydrogen's of the primary amino group is replaced by an acetyl group. It an inhibitor of SARS-CoV and SARS-CoV-2 papain-like protease (PLpro) with an IC50 of 2.6 muM and 5.0 muM, respectively. It also inhibits SARS-CoV and SARS-CoV-2 infection of Vero E6 cells in vitro (EC50 values are 13.1 and 21 muM, respectively). | KOM70144 |
| likviriton | A flavanone glycoside that is liquiritigenin attached to a beta-D-glucopyranosyl residue at position 4' via a glycosidic linkage. | liquiritin |
| loperamide | A synthetic piperidine derivative, effective against diarrhoea resulting from gastroenteritis or inflammatory bowel disease. | loperamide |
| loperamide hydrochloride | A hydrochloride obtained by combining loperamide with one equivalent of hydrochloric acid. Used for treatment of diarrhoea resulting from gastroenteritis or inflammatory bowel disease. | loperamide hydrochloride |
| lopinavir | A dicarboxylic acid diamide that is amphetamine is substituted on nitrogen by a (2,6-dimethylphenoxy)acetyl group and on the carbon alpha- to nitrogen by a (1S,3S)-1-hydroxy-3-{[(2S)-3-methyl-2-(2-oxotetrahydropyrimidin-1-yl)butanoyl]amino}-4-phenylbutyl group. An antiretroviral of the protease inhibitor class, it is used against HIV infections as a fixed-dose combination with another protease inhibitor, ritonavir. | lopinavir |
| lycorine | An indolizidine alkaloid that is 3,12-didehydrogalanthan substituted by hydroxy groups at positions and 2 and a methylenedioxy group across positions 9 and 10. Isolated from Crinum asiaticum, it has been shown to exhibit antimalarial activity. | lycorine |
| mercaptopurine | A member of the class of purines that is 6,7-dihydro-1H-purine carrying a thione group at position 6. An adenine analogue, it is used in the treatment of acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), Crohn's disease, and ulcerative colitis. | 3,7-dihydropurine-6-thione; mercaptopurine; purine-6-thiol |
| methotrimeprazine | A member of the class of phenothiazines that is 10H-phenothiazine substituted by a (2R)-3-(dimethylamino)-2-methylpropyl group and a methoxy group at positions 10 and 2 respectively. | methotrimeprazine |
| miltefosine | A phospholipid that is the hexadecyl monoester of phosphocholine. | miltefosine |
| mizoribine | | Mizoribine |
| molnupiravir | A nucleoside analogue that is N(4)-hydroxycytidine in which the 5'-hydroxy group is replaced by a (2-methylpropanoyl)oxy group. It is the prodrug of the active antiviral ribonucleoside analog N(4)-hydroxycytidine (EIDD-1931), has activity against a number of RNA viruses including SARS-CoV-2, MERS-CoV, and seasonal and pandemic influenza viruses. It is currently in phase III trials for the treatment of patients with COVID-19. | molnupiravir |
| mycophenolate mofetil | A carboxylic ester resulting from the formal condensation between the carboxylic acid group of mycophenolic acid and the hydroxy group of 2-(morpholin-4-yl)ethanol. In the liver, it is metabolised to mycophenolic acid, an immunosuppressant for which it is a prodrug. It is widely used to prevent tissue rejection following organ transplants as well as for the treatment of certain autoimmune diseases. | mycophenolate mofetil |
| mycophenolic acid | A member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one which is substituted at positions 4, 5, 6, and 7 by methyl, methoxy, (2E)-5-carboxy-3-methylpent-2-en-1-yl, and hydroxy groups, respectively. It is an antibiotic produced by Penicillium brevi-compactum, P. stoloniferum, P. echinulatum and related species. An immunosuppressant, it is widely used (partiularly as its sodium salt and as the 2-(morpholin-4-yl)ethyl ester prodrug, mycophenolate mofetil) to prevent tissue rejection following organ transplants and for the treatment of certain autoimmune diseases. | mycophenolic acid |
| N-(4-Butan-2-ylphenyl)-N-[2-(cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide | | N-(4-Butan-2-ylphenyl)-N-[2-(cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]furan-2-carboxamide |
| N-(4-Nitro-1,2,5-oxadiazol-3-yl)-2-pyridin-2-ylsulfanylacetamide | | N-(4-Nitro-1,2,5-oxadiazol-3-yl)-2-pyridin-2-ylsulfanylacetamide |
| N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide | A secondary carboxamide resulting from the formal condensation of the carboxy group of 1H-indole-2-carboxylic acid with the primary amino group of 3-cyclohexyl-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide. It is an inhibitor of SARS coronavirus main proteinase and inhibits SARS-CoV-2 replication in cell culture (EC50 = 0.53 muM). | N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide |
| N-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N-{(2S,3E)-5-(benzyloxy)-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pent-3-en-2-yl}-L-leucinamide | A tripeptide resulting from the formal condensation of the carboxy group of N-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-alanyl-L-valine with the amino group of benzyl (2E,4S)-4-(L-leucylamino)-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate. It is an inhibitor of the main protease of SARS-CoV-2. | N-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N-{(2S,3E)-5-(benzyloxy)-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pent-3-en-2-yl}-L-leucinamide |
| N-[2-(2-Methoxyphenoxy)ethyl]-2-oxo-1H-quinoline-4-carboxamide | | N-[2-(2-Methoxyphenoxy)ethyl]-2-oxo-1H-quinoline-4-carboxamide |
| N-[2-(Cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]-N-(4-propan-2-ylphenyl)furan-2-carboxamide | | N-[2-(Cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]-N-(4-propan-2-ylphenyl)furan-2-carboxamide |
| N-[5-Bromo-1-(2-morpholin-4-ylethyl)-2-oxo-3H-indol-3-yl]acetamide;hydron;chloride | | N-[5-Bromo-1-(2-morpholin-4-ylethyl)-2-oxo-3H-indol-3-yl]acetamide;hydron;chloride |
| N-[5-Ethyl-1-(2-morpholin-4-ylethyl)-2-oxo-3H-indol-3-yl]acetamide;hydron;chloride | | N-[5-Ethyl-1-(2-morpholin-4-ylethyl)-2-oxo-3H-indol-3-yl]acetamide;hydron;chloride |
| N-[5-Fluoro-1-(2-morpholin-4-ylethyl)-2-oxo-3H-indol-3-yl]acetamide;hydron;chloride | | N-[5-Fluoro-1-(2-morpholin-4-ylethyl)-2-oxo-3H-indol-3-yl]acetamide;hydron;chloride |
| N-Cyclopentyl-2-(N-methyl3-chlorobenzenesulfonamido)acetamide | | N-Cyclopentyl-2-(N-methyl3-chlorobenzenesulfonamido)acetamide |
| n(4)-hydroxycytidine | A nucleoside analogue that is cytidine which carries a hydroxy group at the N(4)-positon. It has broad-spectrum antiviral activity against influenza, SARS-CoV , SARS-CoV-2 and MERS-CoV. | N(4)-hydroxycytidine |
| narlaprevir | An azabicyclohexane that is (1R,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane substituted by [(3S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl]aminoacyl and N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl groups at positions 2S and 3, respectively. It is a hepatitis C virus (HCV) NS3/4A serine protease inhibitor (Ki = 6 nM) that is used for the treatment of chronic hepatitis C. | narlaprevir |
| niclosamide | A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections. | niclosamide |
| nirmatrelvir | An azabicyclohexane that is (1R,5S)-3-azabicyclo[3.1.0]hexane substituted by {(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}aminoacyl, 3-methyl-N-(trifluoroacetyl)-L-valinamide, methyl and methyl groups at positions 2S, 3, 6 and 6, respectively. It is the first orally administered inhibitor of SARS-CoV-2 main protease developed by Pfizer and used in combination with ritonavir for the treatment of COVID-19. | nirmatrelvir |
| nutlin-3b | | Nutlin-3 |
| PB28 | A member of the class of tetralins that is tetralin that is substituted by 3-(4-cyclohexylpiperazin-1-yl)propyl and methoxy groups at positions 1 and 5, respectively. It is a sigma 2 (sigma2) receptor agonist (Ki = 0.68 nM) and exhibits antineoplastic and anti SARS-CoV-2 activities. | PB28 |
| PF-00835231 | A primary alcohol resulting from the cleavage of the phosphate group of the prodrug PF-07304814. It is an inhibitor of SARS-CoV-1 and -2 main protease (3CLpro) and exhibits potent in vitro antiviral activity. | PF-00835231 |
| PF-07304814 | An indolecarboxamide resulting from the formal condensation of the carboxy group of 4-methoxy-1H-indole-2-carboxylic acid with the primary amino group of N-[(2S)-3-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]-4-(phosphonooxy)butan-2-yl]-L-leucinamide. It is the phosphate prodrug of PF-00835231, an anticoronaviral agent. | PF-07304814 |
| phenazopyridine | A diaminopyridine that is 2,6-diaminopyridine substituted at position 3 by a phenylazo group. A local anesthetic that has topical analgesic effect on mucosa lining of the urinary tract. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity. | phenazopyridine |
| plitidepsin | A didemnin that is didemin B in which the hydroxy group of the 1-(2-hydroxypropanoyl)-L-prolinamide moiety has been oxidised to the corresponding ketone. It was originally isolated from the Mediterranean tunicate Aplidium albicans. | plitidepsin |
| promethazine | A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety. | promethazine |
| promethazine hydrochloride | The hydrochloride salt of promethazine. | promethazine hydrochloride |
| pyrvinium pamoate | | Pyrvinium pamoate |
| ribavirin | A 1-ribosyltriazole that is the 1-ribofuranosyl derivative of 1,2,4-triazole-3-carboxamide. A synthetic guanosine analogue, it is an inhibitor of HCV polymerase and possesses a broad spectrum of activity against DNA and RNA viruses. | ribavirin |
| s 1033 | | nilotinib |
| s 8932 | A carboxylic ester resulting from the formal condensation of the carboxy group of N-[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]-L-alanine with the hydroxy group of 2-ethylbutan-1-ol. A broad-spectrum antiviral prodrug with potent in vitro antiviral activity against a diverse panel of RNA viruses such as Ebola virus, MERS-CoV and SARS-CoV. It is currently in Phase III clinical trials for the treatment of Covid-19 in adults. | remdesivir |
| saracatinib | A member of the class of quinazolines that is quinazoline substituted by (5-chloro-2H-1,3-benzodioxol-4-yl)amino, (oxan-4-yl)oxy and 2-(4-methylpiperazin-1-yl)ethoxy groups at positions 4, 5 and 7, respectively. It is a dual inhibitor of the tyrosine kinases c-Src and Abl (IC50 = 2.7 and 30 nM, respectively). Saracatinib was originally developed by AstraZeneca for the treatment of cancer but in 2019 it was granted orphan drug designation by the US Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis (IPF), a type of lung disease that results in scarring (fibrosis) of the lungs. | saracatinib |
| savinin | A lignan that is dihydrofuran-2(3H)-one (gamma-butyrolactone) substituted by a 1,3-benzodioxol-5-ylmethylidene group at position 3 and a 1,3-benzodioxol-5-ylmethyl group at position 4 (the 3E,4R-isomer). It exhibits antiviral activity against SARS-CoV-2. | savinin |
| siquil | | triflupromazine hydrochloride |
| sirolimus | A macrolide lactam isolated from Streptomyces hygroscopicus consisting of a 29-membered ring containing 4 trans double bonds, three of which are conjugated. It is an antibiotic, immunosupressive and antineoplastic agent. | sirolimus |
| sorafenib | A member of the class of phenylureas that is urea in which one of the nitrogens is substituted by a 4-chloro-3-trifluorophenyl group while the other is substituted by a phenyl group which, in turn, is substituted at the para position by a [2-(methylcarbamoyl)pyridin-4-yl]oxy group. | sorafenib |
| sotrastaurin | A member of the class of maleimides that is maleimide which is substituted at position 3 by an indol-3-yl group and at position 4 by a quinazolin-4-yl group, which in turn is substituted at position 2 by a 4-methylpiperazin-1-yl group. It is a potent and selective inhibitor of protein kinase C and has been investigated as an immunosuppresant in renal transplant patients. | sotrastaurin |
| tamoxifen citrate | | tamoxifen citrate |
| tanshinone | | Tanshinone I |
| theasinensin a | A biflavonoid that is obtained by coupling of two molecules of (-)-epigallocatechin 3-gallate resulting in a bond between positions C-2 of the hydroxyphenyl ring. It is a natural product found in oolong tea. | theasinensin A |
| thioguanine anhydrous | A 2-aminopurine that is the 6-thiono derivative of 2-amino-1,9-dihydro-6H-purine. Incorporates into DNA and inhibits synthesis. Used in the treatment of leukaemia. | tioguanine |
| thiothixene | | Thiothixene |
| toremifene citrate | | Toremifene citrate |
| trametinib | A pyridopyrimidine that is used (as its dimethyl sulfoxide addition compound) for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and who have not received prior BRAF inhibitor treatment. | trametinib |
| triflupromazine | A member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-(dimethylamino)propyl group at the N-10 position. | triflupromazine |
| triparanol | | triparanol |
| wortmannin | | wortmannin |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 18.5208 | 1 | 12 |
| 15-lipoxygenase, partial | Homo sapiens (human) | Potency | 4.5764 | 1 | 4 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | Leishmania major strain Friedlin | Potency | 3.8082 | 1 | 2 |
| 67.9K protein | Vaccinia virus | Potency | 10.6988 | 2 | 58 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 34.1305 | 3 | 29 |
| acid sphingomyelinase | Homo sapiens (human) | Potency | 10.2663 | 1 | 2 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 22.9485 | 2 | 25 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 20.3851 | 1 | 27 |
| alpha-galactosidase | Homo sapiens (human) | Potency | 31.8884 | 4 | 5 |
| Alpha-synuclein | Homo sapiens (human) | Potency | 10.7746 | 1 | 16 |
| Amyloid-beta precursor protein | Homo sapiens (human) | Potency | 16.3601 | 1 | 1 |
| apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 19.2133 | 1 | 8 |
| AR protein | Homo sapiens (human) | Potency | 21.7580 | 11 | 253 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 21.9091 | 3 | 32 |
| arylsulfatase A | Homo sapiens (human) | Potency | 9.6602 | 1 | 7 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 12.4220 | 11 | 55 |
| Ataxin-2 | Homo sapiens (human) | Potency | 19.4635 | 2 | 31 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 14.2859 | 5 | 18 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 22.7963 | 2 | 32 |
| atrial natriuretic peptide receptor 1 precursor | Homo sapiens (human) | Potency | 3.8306 | 1 | 3 |
| atrial natriuretic peptide receptor 2 precursor | Homo sapiens (human) | Potency | 16.4808 | 1 | 6 |
| beta-2 adrenergic receptor | Homo sapiens (human) | Potency | 6.5131 | 1 | 1 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 36.3514 | 3 | 22 |
| BRCA1 | Homo sapiens (human) | Potency | 17.3330 | 1 | 9 |
| bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 29.5200 | 1 | 20 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 39.2599 | 1 | 17 |
| caspase-3 | Cricetulus griseus (Chinese hamster) | Potency | 37.8935 | 1 | 11 |
| caspase-3 | Homo sapiens (human) | Potency | 39.2599 | 1 | 17 |
| Caspase-7 | Cricetulus griseus (Chinese hamster) | Potency | 37.8935 | 1 | 11 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 22.4995 | 3 | 76 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 12.5971 | 2 | 31 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 20.5048 | 1 | 22 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | Homo sapiens (human) | Potency | 24.8673 | 1 | 5 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 33.9370 | 2 | 27 |
| Chain A, Cruzipain | Trypanosoma cruzi | Potency | 21.3864 | 2 | 7 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 24.3889 | 2 | 12 |
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 11.3820 | 2 | 12 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 32.6071 | 1 | 20 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 13.0959 | 3 | 29 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 15.4291 | 3 | 20 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 19.2994 | 2 | 27 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 11.3820 | 2 | 12 |
| chaperonin-containing TCP-1 beta subunit homolog | Homo sapiens (human) | Potency | 40.1335 | 1 | 3 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 53.1311 | 2 | 26 |
| ClpP | Bacillus subtilis | Potency | 35.4813 | 1 | 1 |
| core-binding factor subunit beta isoform 2 | Homo sapiens (human) | Potency | 29.1318 | 3 | 3 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 6.5134 | 1 | 8 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 8.1008 | 1 | 7 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 18.6907 | 1 | 14 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 8.9582 | 1 | 22 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 9.1709 | 1 | 20 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 15.1928 | 2 | 54 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 14.6694 | 2 | 32 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 13.7933 | 1 | 39 |
| D(1A) dopamine receptor | Homo sapiens (human) | Potency | 3.2378 | 3 | 13 |
| D(1A) dopamine receptor | Sus scrofa (pig) | Potency | 18.1804 | 1 | 7 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | Potency | 8.7683 | 1 | 9 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | Homo sapiens (human) | Potency | 21.9511 | 1 | 3 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | Potency | 18.4508 | 1 | 6 |
| DNA polymerase beta | Homo sapiens (human) | Potency | 27.2642 | 1 | 7 |
| DNA polymerase eta isoform 1 | Homo sapiens (human) | Potency | 50.0613 | 2 | 13 |
| DNA polymerase III, partial | Bacillus subtilis | Potency | 4.7444 | 1 | 1 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 46.6247 | 2 | 34 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 31.5044 | 1 | 13 |
| endonuclease IV | Escherichia coli | Potency | 16.2692 | 2 | 6 |
| Endothelin receptor type B | Rattus norvegicus (Norway rat) | Potency | 22.3872 | 1 | 1 |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | Potency | 22.3872 | 1 | 1 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 18.8120 | 11 | 270 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 32.5701 | 3 | 48 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 19.5544 | 10 | 244 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 23.4529 | 2 | 60 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 13.7655 | 4 | 85 |
| eyes absent homolog 2 isoform a | Homo sapiens (human) | Potency | 19.9526 | 1 | 1 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 27.7962 | 5 | 53 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 44.0487 | 1 | 14 |
| fructose-bisphosphate aldolase A | Oryctolagus cuniculus (rabbit) | Potency | 22.3872 | 1 | 1 |
| Fumarate hydratase | Homo sapiens (human) | Potency | 22.2266 | 1 | 28 |
| G | Vesicular stomatitis virus | Potency | 18.6907 | 1 | 14 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| GALC protein | Homo sapiens (human) | Potency | 0.5517 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 14.9511 | 1 | 28 |
| geminin | Homo sapiens (human) | Potency | 13.3867 | 4 | 113 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 11.5224 | 3 | 77 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 12.8292 | 2 | 31 |
| GLS protein | Homo sapiens (human) | Potency | 15.3235 | 2 | 13 |
| glucocerebrosidase | Homo sapiens (human) | Potency | 23.9875 | 1 | 17 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 25.1032 | 4 | 68 |
| glucokinase regulatory protein | Homo sapiens (human) | Potency | 14.1254 | 1 | 1 |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | Potency | 0.6310 | 1 | 1 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 19.1120 | 2 | 30 |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | Potency | 0.6310 | 1 | 1 |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | Potency | 0.6310 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glycoprotein hormones alpha chain | Homo sapiens (human) | Potency | 6.5912 | 1 | 12 |
| GTP-binding nuclear protein Ran isoform 1 | Homo sapiens (human) | Potency | 14.6552 | 1 | 7 |
| Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 19.5696 | 2 | 15 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | Homo sapiens (human) | Potency | 12.5893 | 1 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Homo sapiens (human) | Potency | 16.3727 | 1 | 5 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 32.2813 | 2 | 18 |
| hemoglobin subunit beta | Homo sapiens (human) | Potency | 13.0630 | 4 | 7 |
| hepatitis C virus polyprotein | | Potency | 7.0456 | 1 | 1 |
| hexokinase-4 isoform 1 | Homo sapiens (human) | Potency | 14.1254 | 1 | 1 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 9.4513 | 2 | 71 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 25.3561 | 1 | 12 |
| histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 6.9161 | 2 | 10 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 57.9920 | 2 | 44 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 41.6385 | 1 | 14 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 18.6907 | 1 | 14 |
| huntingtin isoform 2 | Homo sapiens (human) | Potency | 22.8321 | 1 | 12 |
| hypothetical protein, conserved | Trypanosoma brucei | Potency | 20.7209 | 4 | 10 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 30.4564 | 2 | 16 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 12.3874 | 3 | 17 |
| IDH1 | Homo sapiens (human) | Potency | 14.1000 | 1 | 31 |
| importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 34.5188 | 2 | 13 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 18.6907 | 1 | 28 |
| Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 8.5913 | 2 | 14 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 12.0757 | 1 | 10 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 12.0757 | 1 | 10 |
| Interferon beta | Homo sapiens (human) | Potency | 14.6967 | 3 | 75 |
| interleukin 8 | Homo sapiens (human) | Potency | 70.9011 | 1 | 2 |
| isocitrate dehydrogenase 1, partial | Homo sapiens (human) | Potency | 38.1518 | 4 | 15 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 10.6246 | 3 | 43 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 11.3744 | 1 | 20 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | Homo sapiens (human) | Potency | 19.3559 | 1 | 4 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 21.4599 | 4 | 31 |
| luciferase | Photuris pensylvanica (Pennsylania firefly) | Potency | 18.0789 | 3 | 5 |
| lysosomal alpha-glucosidase preproprotein | Homo sapiens (human) | Potency | 39.8888 | 3 | 6 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 35.6842 | 1 | 13 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 16.2008 | 2 | 40 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 18.3680 | 2 | 11 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 4.8288 | 2 | 13 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 24.9866 | 3 | 13 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 53.1764 | 1 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 53.1764 | 1 | 2 |
| neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 12.1298 | 1 | 13 |
| NFKB1 protein, partial | Homo sapiens (human) | Potency | 20.0443 | 2 | 8 |
| nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 14.1104 | 1 | 20 |
| NPC intracellular cholesterol transporter 1 precursor | Homo sapiens (human) | Potency | 12.0952 | 1 | 13 |
| Nrf2 | Homo sapiens (human) | Potency | 17.7247 | 2 | 7 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 22.7466 | 4 | 68 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 13.0022 | 2 | 23 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | Homo sapiens (human) | Potency | 27.5274 | 1 | 6 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 35.3813 | 2 | 17 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 12.2674 | 1 | 4 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 16.6048 | 2 | 77 |
| nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 9.0564 | 1 | 3 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 23.4911 | 3 | 90 |
| Ornithine decarboxylase | Rattus norvegicus (Norway rat) | Potency | 6.5812 | 1 | 2 |
| P53 | Homo sapiens (human) | Potency | 31.8717 | 1 | 6 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 36.9653 | 1 | 17 |
| Parkin | Homo sapiens (human) | Potency | 4.5221 | 2 | 4 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 63.1940 | 2 | 11 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 19.2068 | 2 | 26 |
| peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 32.5646 | 1 | 12 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 21.7010 | 5 | 68 |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | Potency | 50.1187 | 1 | 2 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 27.2657 | 5 | 59 |
| phosphoglycerate kinase | Trypanosoma brucei brucei TREU927 | Potency | 13.1842 | 1 | 2 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 42.5386 | 2 | 25 |
| PINK1 | Homo sapiens (human) | Potency | 2.9628 | 1 | 3 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 5.5470 | 1 | 16 |
| polyprotein | Zika virus | Potency | 22.2266 | 1 | 28 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | Potency | 15.9839 | 1 | 7 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 10.0186 | 1 | 25 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 8.1823 | 1 | 23 |
| PPM1D protein | Homo sapiens (human) | Potency | 13.8274 | 1 | 36 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 12.8425 | 3 | 41 |
| pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 58.5610 | 1 | 4 |
| progesterone receptor | Homo sapiens (human) | Potency | 31.7460 | 3 | 40 |
| pyruvate kinase | Leishmania mexicana mexicana | Potency | 11.8257 | 5 | 7 |
| pyruvate kinase PKM isoform a | Homo sapiens (human) | Potency | 16.6828 | 4 | 6 |
| pyruvate kinase PKM isoform b | Homo sapiens (human) | Potency | 6.5812 | 2 | 4 |
| Rap guanine nucleotide exchange factor 3 | Homo sapiens (human) | Potency | 54.1202 | 2 | 16 |
| Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 40.5418 | 1 | 6 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 14.7269 | 2 | 71 |
| ras-related protein Rab-9A | Homo sapiens (human) | Potency | 23.7388 | 1 | 16 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 20.7179 | 1 | 15 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 19.9164 | 3 | 104 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 11.6151 | 4 | 70 |
| RGS12 | Homo sapiens (human) | Potency | 12.5893 | 1 | 1 |
| runt-related transcription factor 1 isoform AML1b | Homo sapiens (human) | Potency | 29.1318 | 3 | 3 |
| serine-protein kinase ATM isoform a | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | Homo sapiens (human) | Potency | 14.9693 | 7 | 27 |
| serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Potency | 17.2642 | 1 | 8 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Potency | 5.7988 | 1 | 1 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 29.6314 | 3 | 21 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 29.6314 | 3 | 21 |
| Smad3 | Homo sapiens (human) | Potency | 14.0961 | 4 | 36 |
| snurportin-1 | Homo sapiens (human) | Potency | 34.5188 | 2 | 13 |
| Sodium channel protein type 1 subunit alpha | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Sodium channel protein type 2 subunit alpha | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Sodium channel protein type 3 subunit alpha | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 16.3019 | 2 | 26 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 10.1986 | 2 | 38 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 17.9956 | 1 | 19 |
| TDP1 protein | Homo sapiens (human) | Potency | 11.3885 | 2 | 198 |
| thioredoxin glutathione reductase | Schistosoma mansoni | Potency | 16.3968 | 1 | 16 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 21.5722 | 3 | 33 |
| Thrombopoietin | Homo sapiens (human) | Potency | 10.6172 | 2 | 20 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 12.9916 | 3 | 86 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 29.2461 | 4 | 11 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 30.5640 | 6 | 50 |
| thyrotropin-releasing hormone receptor | Homo sapiens (human) | Potency | 27.1509 | 2 | 9 |
| transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 27.2249 | 1 | 4 |
| transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | Potency | 20.0203 | 1 | 3 |
| TSHR protein | Homo sapiens (human) | Potency | 92.5374 | 2 | 3 |
| tyrosine-protein kinase Yes | Homo sapiens (human) | Potency | 15.5217 | 2 | 7 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | Homo sapiens (human) | Potency | 8.7683 | 1 | 9 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 5.5470 | 1 | 16 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 5.5470 | 1 | 16 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 51.8553 | 3 | 32 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 17.8203 | 2 | 38 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 21.6445 | 5 | 49 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 40.5009 | 5 | 36 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 19.7493 | 1 | 29 |
| Vpr | Human immunodeficiency virus 1 | Potency | 30.0334 | 1 | 5 |
| WRN | Homo sapiens (human) | Potency | 34.5489 | 2 | 10 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Homo sapiens (human) | IC50 | 6.7000 | 1 | 1 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | IC50 | 1.7735 | 4 | 4 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Escherichia coli K-12 | IC50 | 2.2000 | 1 | 1 |
| 14 kDa phosphohistidine phosphatase | Homo sapiens (human) | Ki | 209.0000 | 1 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | Homo sapiens (human) | Ki | 0.0110 | 1 | 1 |
| 3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | IC50 | 46.9500 | 2 | 2 |
| 3C-like protease, partial | Infectious bronchitis virus | IC50 | 5.6067 | 1 | 36 |
| 4-aminobutyrate aminotransferase, mitochondrial | Homo sapiens (human) | IC50 | 12,800.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | IC50 | 1.9394 | 2 | 5 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | Ki | 0.8000 | 3 | 4 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Ki | 2.3397 | 3 | 6 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | IC50 | 1.9394 | 2 | 5 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | Ki | 2.1483 | 4 | 7 |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 1 | 1 |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | Ki | 4.2500 | 2 | 2 |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 1 | 1 |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | Ki | 4.2500 | 2 | 2 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | IC50 | 0.0271 | 2 | 7 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 | 0.0035 | 2 | 2 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | Ki | 0.1441 | 10 | 15 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | Ki | 0.0039 | 7 | 7 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | IC50 | 0.7648 | 1 | 6 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | IC50 | 0.0035 | 2 | 2 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | Ki | 0.3409 | 4 | 9 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Ki | 0.0039 | 7 | 7 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | IC50 | 0.0594 | 1 | 5 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | IC50 | 0.0035 | 2 | 2 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 0.0818 | 6 | 11 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | Ki | 0.0039 | 7 | 7 |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | Ki | 0.7000 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | Ki | 0.7000 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | IC50 | 0.0594 | 1 | 5 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | Ki | 0.0312 | 1 | 5 |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 1 | 1 |
| 5-hydroxytryptamine receptor 5A | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 1 | 1 |
| 5-hydroxytryptamine receptor 5A | Homo sapiens (human) | Ki | 3.2960 | 1 | 1 |
| 5-hydroxytryptamine receptor 5B | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 1 | 1 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | IC50 | 1.2098 | 1 | 5 |
| 5-hydroxytryptamine receptor 6 | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 1 | 1 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | Ki | 0.7236 | 7 | 13 |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | IC50 | 43.0200 | 1 | 10 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | IC50 | 275.0000 | 1 | 2 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | Ki | 0.9838 | 6 | 8 |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | Ki | 0.0210 | 1 | 1 |
| 5'-nucleotidase | Homo sapiens (human) | IC50 | 43.2600 | 1 | 1 |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | IC50 | 85.3367 | 3 | 3 |
| Acetylcholinesterase | Homo sapiens (human) | IC50 | 84.2000 | 4 | 5 |
| Acetylcholinesterase | Homo sapiens (human) | Ki | 68.9959 | 6 | 46 |
| Acetylcholinesterase | Mus musculus (house mouse) | Ki | 0.7500 | 1 | 1 |
| Activated CDC42 kinase 1 | Homo sapiens (human) | Ki | 0.0100 | 1 | 1 |
| Adenosine receptor A1 | Homo sapiens (human) | Ki | 7.4100 | 2 | 2 |
| Adenosine receptor A1 | Mus musculus (house mouse) | Ki | 4.4300 | 1 | 1 |
| Adenosine receptor A2a | Homo sapiens (human) | Ki | 7.4100 | 1 | 1 |
| Adenosine receptor A3 | Homo sapiens (human) | IC50 | 20.9140 | 1 | 3 |
| Adenosine receptor A3 | Homo sapiens (human) | Ki | 10.7188 | 2 | 4 |
| Adenylate cyclase type 1 | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Adenylate cyclase type 1 | Rattus norvegicus (Norway rat) | Ki | 0.1180 | 1 | 1 |
| Adenylate cyclase type 2 | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Adenylate cyclase type 2 | Rattus norvegicus (Norway rat) | Ki | 0.1180 | 1 | 1 |
| Adenylate cyclase type 3 | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Adenylate cyclase type 3 | Rattus norvegicus (Norway rat) | Ki | 0.1180 | 1 | 1 |
| Adenylate cyclase type 4 | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Adenylate cyclase type 4 | Rattus norvegicus (Norway rat) | Ki | 0.1180 | 1 | 1 |
| Adenylate cyclase type 5 | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Adenylate cyclase type 5 | Rattus norvegicus (Norway rat) | Ki | 0.1180 | 1 | 1 |
| Adenylate cyclase type 6 | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Adenylate cyclase type 6 | Rattus norvegicus (Norway rat) | Ki | 0.1180 | 1 | 1 |
| Adenylate cyclase type 8 | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Adenylate cyclase type 8 | Rattus norvegicus (Norway rat) | Ki | 0.1180 | 1 | 1 |
| Adenylyl cyclase 7 | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Adenylyl cyclase 7 | Rattus norvegicus (Norway rat) | Ki | 0.1180 | 1 | 1 |
| Aldehyde oxidase | Homo sapiens (human) | IC50 | 0.5700 | 1 | 1 |
| Aldehyde oxidase | Homo sapiens (human) | Ki | 2.3000 | 1 | 1 |
| Aldehyde oxidase 1 | Oryctolagus cuniculus (rabbit) | IC50 | 20.0000 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | IC50 | 1.5330 | 1 | 5 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | Ki | 1.5204 | 1 | 5 |
| ALK tyrosine kinase receptor | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 10.3055 | 5 | 8 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 5.6556 | 6 | 9 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 11.7777 | 4 | 7 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 5.6556 | 6 | 9 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | IC50 | 0.9902 | 1 | 6 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 4.9255 | 3 | 4 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | Ki | 0.4867 | 1 | 6 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 2.5725 | 5 | 6 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | IC50 | 1.0780 | 2 | 7 |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.7402 | 2 | 2 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | Ki | 1.6849 | 2 | 9 |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.0760 | 2 | 3 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | IC50 | 0.6747 | 2 | 6 |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.7402 | 2 | 2 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | Ki | 14.4059 | 2 | 8 |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.0760 | 2 | 3 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | IC50 | 0.9304 | 2 | 7 |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.7402 | 2 | 2 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | Ki | 3.0303 | 2 | 9 |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.0760 | 2 | 3 |
| Alpha-synuclein | Homo sapiens (human) | IC50 | 8.2000 | 1 | 1 |
| Amyloid-beta precursor protein | Homo sapiens (human) | IC50 | 7.3000 | 2 | 4 |
| Androgen receptor | Rattus norvegicus (Norway rat) | Ki | 0.8000 | 1 | 1 |
| Angiopoietin-1 receptor | Homo sapiens (human) | IC50 | 11.3027 | 6 | 6 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | IC50 | 5.7666 | 1 | 2 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | Ki | 4.7244 | 1 | 2 |
| Angiotensin-converting enzyme | Homo sapiens (human) | Ki | 715.0000 | 1 | 1 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | IC50 | 8.6895 | 2 | 23 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | Ki | 0.0075 | 1 | 1 |
| Anoctamin-1 | Homo sapiens (human) | IC50 | 0.0280 | 1 | 1 |
| Apoptosis regulator Bcl-2 | Homo sapiens (human) | GI50 | 147.0000 | 1 | 1 |
| Aromatase | Homo sapiens (human) | IC50 | 0.1269 | 1 | 7 |
| Arrestin, beta 1 | Homo sapiens (human) | IC50 | 1.5240 | 1 | 1 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 109.2724 | 2 | 17 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 11.8047 | 46 | 61 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | IC50 | 2.1250 | 4 | 8 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | Ki | 4.3122 | 8 | 9 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | Ki | 3.5750 | 2 | 2 |
| Aurora kinase A | Homo sapiens (human) | IC50 | 11.9888 | 6 | 6 |
| Aurora kinase B | Homo sapiens (human) | IC50 | 26.5470 | 4 | 5 |
| Bcl-2-like protein 1 | Homo sapiens (human) | GI50 | 183.0000 | 1 | 1 |
| Beta lactamase (plasmid) | Pseudomonas aeruginosa | IC50 | 49.7465 | 1 | 2 |
| Beta-1 adrenergic receptor | Homo sapiens (human) | IC50 | 17.3820 | 1 | 1 |
| Beta-1 adrenergic receptor | Homo sapiens (human) | Ki | 10.0370 | 1 | 1 |
| Beta-2 adrenergic receptor | Homo sapiens (human) | IC50 | 3.0050 | 1 | 1 |
| Beta-2 adrenergic receptor | Homo sapiens (human) | Ki | 2.0660 | 1 | 1 |
| Beta-3 adrenergic receptor | Homo sapiens (human) | IC50 | 18.7740 | 1 | 2 |
| Beta-3 adrenergic receptor | Homo sapiens (human) | Ki | 14.0805 | 1 | 2 |
| Beta-secretase 1 | Homo sapiens (human) | IC50 | 9.8500 | 2 | 2 |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | IC50 | 0.6084 | 5 | 5 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 60.2565 | 10 | 51 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 61.4500 | 1 | 2 |
| Bile salt export pump | Homo sapiens (human) | Ki | 9.5000 | 1 | 1 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | Ki | 0.3000 | 1 | 1 |
| Botulinum neurotoxin type A | Clostridium botulinum | IC50 | 100.0000 | 1 | 1 |
| Breakpoint cluster region protein | Homo sapiens (human) | GI50 | 0.6808 | 19 | 35 |
| Breakpoint cluster region protein | Mus musculus (house mouse) | GI50 | 0.0010 | 1 | 1 |
| Breakpoint cluster region protein | Homo sapiens (human) | IC50 | 0.2638 | 26 | 28 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | IC50 | 10.3960 | 8 | 9 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | Ki | 0.5000 | 1 | 1 |
| C-8 sterol isomerase | Saccharomyces cerevisiae S288C | Ki | 0.0020 | 1 | 1 |
| CAAX prenyl protease 1 homolog | Mus musculus (house mouse) | IC50 | 18.4000 | 1 | 1 |
| Calcineurin subunit B type 1 | Homo sapiens (human) | IC50 | 34.0000 | 1 | 1 |
| Calmodulin | Bos taurus (cattle) | IC50 | 5.6667 | 2 | 3 |
| Calmodulin-1 | Homo sapiens (human) | IC50 | 21.3900 | 3 | 4 |
| Calmodulin-1 | Homo sapiens (human) | Ki | 19.2800 | 1 | 1 |
| calpain II, partial | Sus scrofa (pig) | IC50 | 1.7742 | 1 | 1 |
| Calpain-1 catalytic subunit | Homo sapiens (human) | IC50 | 8.9649 | 4 | 8 |
| Calpain-9 | Homo sapiens (human) | IC50 | 42.2900 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 90.2081 | 6 | 21 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | Ki | 11.2700 | 3 | 3 |
| Canalicular multispecific organic anion transporter 1 | Rattus norvegicus (Norway rat) | Ki | 6.6367 | 2 | 3 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 5.0146 | 2 | 2 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Ki | 0.3020 | 1 | 1 |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | Ki | 4.6650 | 1 | 1 |
| Carbonic anhydrase 14 | Homo sapiens (human) | Ki | 0.2230 | 1 | 1 |
| Carbonic anhydrase 15 | Mus musculus (house mouse) | Ki | 0.0790 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 5.0020 | 2 | 2 |
| Carbonic anhydrase 3 | Homo sapiens (human) | Ki | 0.4430 | 1 | 1 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Ki | 0.4460 | 1 | 1 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | Ki | 5.4850 | 1 | 1 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | Ki | 14.9200 | 1 | 1 |
| Carbonic anhydrase 6 | Homo sapiens (human) | Ki | 0.4610 | 1 | 1 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Ki | 4.1177 | 2 | 2 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Ki | 5.0210 | 2 | 2 |
| Casein kinase I isoform alpha | Homo sapiens (human) | IC50 | 0.1255 | 1 | 2 |
| Casein kinase II subunit alpha | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Casein kinase II subunit alpha 3 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Casein kinase II subunit beta | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| caspase recruitment domain family, member 15 | Homo sapiens (human) | IC50 | 26.4500 | 1 | 2 |
| Caspase-1 | Homo sapiens (human) | IC50 | 3.5200 | 2 | 2 |
| Caspase-2 | Homo sapiens (human) | IC50 | 6.5000 | 2 | 2 |
| Caspase-3 | Homo sapiens (human) | IC50 | 2.0000 | 2 | 2 |
| Caspase-4 | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
| Caspase-6 | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
| Caspase-7 | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
| Caspase-8 | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
| Caspase-9 | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
| Cathepsin B | Homo sapiens (human) | IC50 | 2.3062 | 4 | 8 |
| Cathepsin D | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Cathepsin G | Homo sapiens (human) | IC50 | 50.5500 | 2 | 2 |
| Cathepsin G | Mus musculus (house mouse) | IC50 | 10.0000 | 1 | 1 |
| Cathepsin K | Homo sapiens (human) | IC50 | 0.2918 | 1 | 5 |
| Chain A, Histamine N-methyltransferase | Homo sapiens (human) | Ki | 0.0186 | 1 | 4 |
| Chain A, Inosine-5'-Monophosphate Dehydrogenase 2 | Cricetulus griseus (Chinese hamster) | Ki | 0.0060 | 1 | 1 |
| Chain A, Protease | Human immunodeficiency virus 1 | Ki | 0.0000 | 1 | 4 |
| Chain A, PROTEASE RETROPEPSIN | Human immunodeficiency virus 1 | Ki | 0.0038 | 1 | 5 |
| Chain A, Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | IC50 | 0.0027 | 1 | 1 |
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | IC50 | 62.5600 | 1 | 2 |
| Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 | Homo sapiens (human) | Ki | 0.0005 | 1 | 5 |
| Chain B, Protease | Human immunodeficiency virus 1 | Ki | 0.0000 | 1 | 4 |
| Chain B, Protease Retropepsin | Human immunodeficiency virus 1 | Ki | 0.0038 | 1 | 5 |
| Chloroquine resistance transporter | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 85.0000 | 1 | 1 |
| Cholinesterase | Equus caballus (horse) | IC50 | 57.0870 | 4 | 4 |
| Cholinesterase | Homo sapiens (human) | Ki | 72.7395 | 2 | 38 |
| Chymotrypsinogen A | Bos taurus (cattle) | IC50 | 100.0000 | 1 | 1 |
| Chymotrypsinogen B | Homo sapiens (human) | IC50 | 34.0000 | 1 | 1 |
| coagulation factor XI | Homo sapiens (human) | IC50 | 1.4323 | 1 | 3 |
| Coagulation factor XII | Homo sapiens (human) | IC50 | 25.6957 | 1 | 2 |
| Coagulation factor XII | Homo sapiens (human) | Ki | 67.6281 | 1 | 32 |
| Cocaine esterase | Homo sapiens (human) | IC50 | 5.7000 | 2 | 2 |
| Cocaine esterase | Homo sapiens (human) | Ki | 2.8341 | 3 | 7 |
| COUP transcription factor 2 isoform a | Homo sapiens (human) | IC50 | 1.3150 | 1 | 1 |
| Cruzipain | Trypanosoma cruzi | IC50 | 66.6250 | 4 | 8 |
| Cyclic GMP-AMP synthase | Homo sapiens (human) | IC50 | 23.0000 | 1 | 1 |
| Cyclin-A1 | Homo sapiens (human) | IC50 | 2.3000 | 1 | 1 |
| Cyclin-A2 | Homo sapiens (human) | IC50 | 501.1500 | 2 | 2 |
| Cyclin-C | Homo sapiens (human) | IC50 | 0.0662 | 2 | 2 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | IC50 | 340.2967 | 2 | 3 |
| Cyclin-dependent kinase 19 | Homo sapiens (human) | IC50 | 0.2060 | 1 | 1 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | IC50 | 195.3833 | 6 | 6 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | IC50 | 3.0000 | 2 | 2 |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | IC50 | 0.1300 | 1 | 1 |
| Cyclin-dependent kinase 8 | Homo sapiens (human) | IC50 | 2.0165 | 10 | 10 |
| Cys-loop ligand-gated ion channel | Dickeya chrysanthemi | IC50 | 158.0000 | 1 | 1 |
| Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 14.2733 | 3 | 3 |
| Cytochrome P450 11B1, mitochondrial | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 1 |
| Cytochrome P450 1A1 | Homo sapiens (human) | Ki | 1.2200 | 1 | 1 |
| Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 50.0005 | 4 | 5 |
| Cytochrome P450 1B1 | Homo sapiens (human) | Ki | 0.2600 | 1 | 1 |
| Cytochrome P450 2A6 | Homo sapiens (human) | IC50 | 35.0000 | 1 | 1 |
| Cytochrome P450 2B6 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Cytochrome P450 2C19 | Homo sapiens (human) | IC50 | 40.2500 | 4 | 4 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 35.0271 | 6 | 7 |
| Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 51.1893 | 4 | 5 |
| Cytochrome P450 2D6 | Homo sapiens (human) | Ki | 7.0000 | 1 | 1 |
| Cytochrome P450 2J2 | Homo sapiens (human) | IC50 | 12.6950 | 1 | 2 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 29.0413 | 14 | 17 |
| Cytochrome P450 3A4 | Homo sapiens (human) | Ki | 4.2717 | 3 | 6 |
| Cytochrome P450 3A43 | Homo sapiens (human) | IC50 | 2.0600 | 1 | 1 |
| Cytochrome P450 3A43 | Homo sapiens (human) | Ki | 7.6000 | 1 | 2 |
| Cytochrome P450 3A5 | Homo sapiens (human) | IC50 | 2.0600 | 1 | 1 |
| Cytochrome P450 3A5 | Homo sapiens (human) | Ki | 7.6000 | 1 | 2 |
| Cytochrome P450 3A7 | Homo sapiens (human) | IC50 | 2.0600 | 1 | 1 |
| Cytochrome P450 3A7 | Homo sapiens (human) | Ki | 7.6000 | 1 | 2 |
| D | Bos taurus (cattle) | IC50 | 0.6460 | 4 | 4 |
| D | Rattus norvegicus (Norway rat) | IC50 | 0.1414 | 9 | 14 |
| D | Rattus norvegicus (Norway rat) | Ki | 0.0337 | 3 | 4 |
| D(1A) dopamine receptor | Homo sapiens (human) | IC50 | 1.6230 | 1 | 5 |
| D(1A) dopamine receptor | Homo sapiens (human) | Ki | 0.6189 | 2 | 7 |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0416 | 7 | 12 |
| D(1B) dopamine receptor | Homo sapiens (human) | Ki | 0.0965 | 1 | 2 |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 0.0140 | 1 | 1 |
| D(2) dopamine receptor | Bos taurus (cattle) | IC50 | 0.5328 | 5 | 5 |
| D(2) dopamine receptor | Homo sapiens (human) | IC50 | 0.5886 | 5 | 10 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0365 | 10 | 16 |
| D(2) dopamine receptor | Homo sapiens (human) | Ki | 0.4783 | 12 | 17 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 0.0105 | 9 | 10 |
| D(3) dopamine receptor | Homo sapiens (human) | IC50 | 0.4139 | 1 | 6 |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 0.2530 | 8 | 13 |
| D(3) dopamine receptor | Homo sapiens (human) | Ki | 0.1672 | 9 | 17 |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 0.0140 | 1 | 1 |
| D(4) dopamine receptor | Homo sapiens (human) | IC50 | 4.4430 | 1 | 3 |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0416 | 7 | 12 |
| D(4) dopamine receptor | Homo sapiens (human) | Ki | 0.9444 | 4 | 7 |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 0.0140 | 1 | 1 |
| Death-associated protein kinase 1 | Homo sapiens (human) | IC50 | 120.0000 | 1 | 1 |
| Delta-type opioid receptor | Homo sapiens (human) | IC50 | 11.7856 | 2 | 5 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.5000 | 1 | 1 |
| Delta-type opioid receptor | Homo sapiens (human) | Ki | 5.1822 | 1 | 4 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 1.1251 | 2 | 2 |
| Dihydrofolate reductase | Homo sapiens (human) | IC50 | 0.0018 | 1 | 1 |
| Dihydrofolate reductase | Bos taurus (cattle) | IC50 | 0.0301 | 2 | 2 |
| Dihydroorotase | Bacillus anthracis | IC50 | 100.0000 | 1 | 2 |
| Dihydroorotate dehydrogenase | Leishmania major | IC50 | 1,037.0000 | 1 | 2 |
| Dihydroorotate dehydrogenase | Schistosoma mansoni | IC50 | 20.0000 | 2 | 2 |
| Dihydroorotate dehydrogenase (quinone), mitochondrial | Homo sapiens (human) | IC50 | 1.8629 | 27 | 27 |
| Dihydroorotate dehydrogenase (quinone), mitochondrial | Rattus norvegicus (Norway rat) | IC50 | 0.2042 | 4 | 5 |
| Dihydroorotate dehydrogenase (quinone), mitochondrial | Homo sapiens (human) | Ki | 0.0120 | 2 | 2 |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | IC50 | 212.5000 | 1 | 2 |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | GI50 | 2.2000 | 1 | 2 |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | IC50 | 0.0653 | 10 | 18 |
| DNA ligase | Tequatrovirus T4 | IC50 | 823.0000 | 2 | 4 |
| DNA ligase 1 | Homo sapiens (human) | IC50 | 823.0000 | 2 | 4 |
| DNA ligase A | Mycobacterium tuberculosis H37Rv | IC50 | 823.0000 | 2 | 4 |
| DNA polymerase alpha catalytic subunit | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| DNA polymerase beta | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | IC50 | 50.0000 | 1 | 2 |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | Ki | 0.1200 | 2 | 2 |
| DNA-directed RNA polymerase, mitochondrial | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Dual serine/threonine and tyrosine protein kinase | Homo sapiens (human) | IC50 | 29.3500 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | IC50 | 2.5224 | 16 | 17 |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | IC50 | 3.5750 | 9 | 10 |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | IC50 | 6.8540 | 2 | 2 |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | Ki | 0.1984 | 1 | 1 |
| ELAV-like protein 1 | Homo sapiens (human) | IC50 | 0.1085 | 2 | 2 |
| ELAV-like protein 1 | Homo sapiens (human) | Ki | 0.0500 | 1 | 1 |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | IC50 | 3.1688 | 4 | 9 |
| Ephrin type-A receptor 2 | Homo sapiens (human) | IC50 | 0.0569 | 2 | 3 |
| Ephrin type-B receptor 2 | Homo sapiens (human) | IC50 | 0.0044 | 1 | 1 |
| Ephrin type-B receptor 4 | Homo sapiens (human) | IC50 | 1.5345 | 7 | 9 |
| Epidermal growth factor receptor | Homo sapiens (human) | IC50 | 7.2023 | 18 | 22 |
| Epithelial discoidin domain-containing receptor 1 | Homo sapiens (human) | GI50 | 2.0500 | 1 | 2 |
| Epithelial discoidin domain-containing receptor 1 | Homo sapiens (human) | IC50 | 0.0280 | 6 | 10 |
| Epithelial discoidin domain-containing receptor 1 | Homo sapiens (human) | Ki | 0.0100 | 1 | 1 |
| Estrogen receptor | Homo sapiens (human) | IC50 | 1.7000 | 1 | 1 |
| Estrogen receptor beta | Homo sapiens (human) | IC50 | 0.0050 | 1 | 1 |
| Eukaryotic initiation factor 4A-I | Homo sapiens (human) | IC50 | 0.1390 | 4 | 4 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | Homo sapiens (human) | IC50 | 3.4550 | 1 | 2 |
| eukaryotic translation initiation factor 4E isoform 1 | Mus musculus (house mouse) | IC50 | 3.4550 | 1 | 2 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | IC50 | 6.1000 | 1 | 1 |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | IC50 | 1.7658 | 10 | 16 |
| Fibronectin | Homo sapiens (human) | IC50 | 1.9400 | 1 | 3 |
| fMet-Leu-Phe receptor | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Focal adhesion kinase 1 | Homo sapiens (human) | IC50 | 29.1500 | 2 | 2 |
| Fructose-1,6-bisphosphatase 1 | Homo sapiens (human) | IC50 | 29.0000 | 1 | 1 |
| Fumarate reductase | Ascaris suum (pig roundworm) | IC50 | 0.5000 | 1 | 1 |
| Furin | Homo sapiens (human) | IC50 | 0.0180 | 1 | 1 |
| Furin | Homo sapiens (human) | Ki | 3.4394 | 1 | 6 |
| G protein-coupled receptor kinase 6 | Homo sapiens (human) | IC50 | 8.7000 | 1 | 1 |
| G-protein coupled receptor 35 | Homo sapiens (human) | IC50 | 28.2000 | 1 | 1 |
| G1/S-specific cyclin-D1 | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | IC50 | 10.4450 | 1 | 2 |
| Gag-Pol polyprotein | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | IC50 | 0.0350 | 1 | 1 |
| Gag-Pol polyprotein | HIV-1 M:B_ARV2/SF2 | Ki | 0.0018 | 1 | 4 |
| Gag-Pol polyprotein | Human immunodeficiency virus type 1 (BRU ISOLATE) | Ki | 0.0017 | 1 | 6 |
| Gag-Pol polyprotein | Human immunodeficiency virus type 1 (RF/HAT ISOLATE) | Ki | 0.0017 | 1 | 6 |
| Gag-Pol polyprotein | Human immunodeficiency virus type 1 (STRAIN UGANDAN / ISOLATE U455) | Ki | 0.0017 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-butyrobetaine dioxygenase | Homo sapiens (human) | IC50 | 0.7420 | 5 | 5 |
| Gastrin/cholecystokinin type B receptor | Mus musculus (house mouse) | Ki | 0.0033 | 1 | 2 |
| Genome polyprotein | Hepatitis C virus (isolate Japanese) | IC50 | 100.0000 | 1 | 2 |
| Genome polyprotein | rhinovirus A16 | IC50 | 0.0800 | 1 | 1 |
| Genome polyprotein | Human rhinovirus sp. | IC50 | 0.0040 | 1 | 1 |
| Genome polyprotein | | Ki | 0.0060 | 1 | 1 |
| Genome polyprotein | Human rhinovirus sp. | Ki | 0.0040 | 1 | 1 |
| Genome polyprotein | Zika virus | Ki | 92.3000 | 1 | 1 |
| Ghrelin O-acyltransferase | Homo sapiens (human) | IC50 | 433.0000 | 1 | 1 |
| Glucocorticoid receptor | Homo sapiens (human) | IC50 | 19.0000 | 1 | 1 |
| Glucose transporter | Leishmania mexicana | IC50 | 0.1827 | 1 | 3 |
| glucose-6-phosphate 1-dehydrogenase isoform b | Homo sapiens (human) | IC50 | 57.7333 | 2 | 3 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | IC50 | 46.8844 | 6 | 9 |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | IC50 | 0.0140 | 1 | 1 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | IC50 | 0.0140 | 1 | 1 |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | IC50 | 0.0140 | 1 | 1 |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | IC50 | 0.0140 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | IC50 | 0.8500 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | IC50 | 0.8500 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | IC50 | 0.8500 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | IC50 | 0.8500 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | Ki | 92.6000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | IC50 | 0.8500 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | IC50 | 0.8500 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | IC50 | 0.8500 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | IC50 | 1.3000 | 1 | 1 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | IC50 | 19.7600 | 6 | 7 |
| GTPase KRas | Homo sapiens (human) | IC50 | 5.8800 | 1 | 1 |
| Heat shock factor protein 1 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Hepatocyte growth factor activator | Homo sapiens (human) | IC50 | 32.0000 | 1 | 1 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | IC50 | 7.8750 | 2 | 2 |
| hepatocyte nuclear factor 4-alpha isoform 2 | Homo sapiens (human) | IC50 | 7.8660 | 1 | 1 |
| hexokinase | Trypanosoma brucei brucei TREU927 | IC50 | 0.9009 | 1 | 1 |
| hexokinase HKDC1 | Homo sapiens (human) | IC50 | 43.4925 | 2 | 8 |
| Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 0.2420 | 1 | 3 |
| Histamine H1 receptor | Homo sapiens (human) | IC50 | 0.0252 | 2 | 7 |
| Histamine H1 receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0002 | 1 | 2 |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.1585 | 1 | 1 |
| Histamine H1 receptor | Homo sapiens (human) | Ki | 0.0070 | 5 | 10 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.7200 | 1 | 1 |
| Histamine H2 receptor | Homo sapiens (human) | IC50 | 1.9715 | 1 | 6 |
| Histamine H2 receptor | Homo sapiens (human) | Ki | 1.9387 | 1 | 6 |
| Histamine H3 receptor | Homo sapiens (human) | Ki | 1.0000 | 1 | 2 |
| Histamine H4 receptor | Homo sapiens (human) | Ki | 8.9716 | 2 | 2 |
| Histidine-rich protein PFHRP-II | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 396,967.5905 | 13 | 13 |
| Histone acetyltransferase KAT2B | Homo sapiens (human) | IC50 | 19.4500 | 4 | 4 |
| Histone acetyltransferase KAT5 | Homo sapiens (human) | IC50 | 64.0000 | 1 | 1 |
| Histone acetyltransferase KAT8 | Homo sapiens (human) | IC50 | 43.0000 | 1 | 1 |
| Histone acetyltransferase KAT8 | Homo sapiens (human) | Ki | 64.0000 | 1 | 1 |
| Histone acetyltransferase p300 | Homo sapiens (human) | IC50 | 7.4125 | 4 | 4 |
| Histone deacetylase 5 | Homo sapiens (human) | IC50 | 3.4000 | 1 | 1 |
| Histone deacetylase 6 | Homo sapiens (human) | IC50 | 6.5333 | 3 | 3 |
| Histone deacetylase 9 | Homo sapiens (human) | IC50 | 3.7000 | 1 | 1 |
| Histone-lysine N-methyltransferase EHMT1 | Homo sapiens (human) | IC50 | 0.7300 | 1 | 1 |
| Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
| Histone-lysine N-methyltransferase EZH2 | Homo sapiens (human) | IC50 | 8.9000 | 1 | 1 |
| Homeodomain-interacting protein kinase 1 | Homo sapiens (human) | IC50 | 0.1000 | 1 | 1 |
| Homeodomain-interacting protein kinase 2 | Homo sapiens (human) | IC50 | 0.1000 | 1 | 1 |
| Homeodomain-interacting protein kinase 3 | Homo sapiens (human) | IC50 | 0.1000 | 1 | 1 |
| Homeodomain-interacting protein kinase 4 | Homo sapiens (human) | IC50 | 0.0515 | 2 | 2 |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | IC50 | 3.1688 | 4 | 9 |
| Ileal sodium/bile acid cotransporter | Homo sapiens (human) | Ki | 24.0000 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | Ki | 0.0940 | 3 | 3 |
| Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Inosine-5'-monophosphate dehydrogenase | Cryptococcus neoformans var. neoformans JEC21 | IC50 | 0.1200 | 1 | 1 |
| Inosine-5'-monophosphate dehydrogenase 1 | Homo sapiens (human) | IC50 | 3.3977 | 6 | 6 |
| Inosine-5'-monophosphate dehydrogenase 1 | Homo sapiens (human) | Ki | 0.0365 | 8 | 8 |
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | IC50 | 1.1421 | 20 | 20 |
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | Ki | 0.0084 | 8 | 8 |
| Insulin receptor | Homo sapiens (human) | IC50 | 28.8250 | 3 | 4 |
| Insulin-degrading enzyme | Homo sapiens (human) | IC50 | 33.3520 | 3 | 3 |
| Insulin-like growth factor 1 receptor | Homo sapiens (human) | IC50 | 30.0000 | 2 | 2 |
| Integrase | Human immunodeficiency virus 1 | IC50 | 3.2960 | 5 | 5 |
| Interleukin-2 | Mus musculus (house mouse) | IC50 | 0.0050 | 1 | 1 |
| Kallikrein-1 | Homo sapiens (human) | IC50 | 34.1000 | 1 | 1 |
| kallikrein-5 preproprotein | Homo sapiens (human) | IC50 | 1.9003 | 1 | 2 |
| Kappa-type opioid receptor | Homo sapiens (human) | IC50 | 9.1410 | 2 | 5 |
| Kappa-type opioid receptor | Homo sapiens (human) | Ki | 4.5550 | 1 | 4 |
| Lactoylglutathione lyase | Homo sapiens (human) | IC50 | 11.0000 | 1 | 1 |
| large T antigen | Betapolyomavirus macacae | IC50 | 13.9100 | 1 | 1 |
| LIM domain kinase 1 | Homo sapiens (human) | IC50 | 0.6097 | 5 | 5 |
| LIM domain kinase 2 | Homo sapiens (human) | IC50 | 0.5186 | 4 | 4 |
| Linoleate 9S-lipoxygenase-4 | Glycine max (soybean) | IC50 | 22.0000 | 1 | 1 |
| Liver carboxylesterase 1 | Homo sapiens (human) | Ki | 62.2222 | 3 | 41 |
| Liver carboxylesterase 1 | Oryctolagus cuniculus (rabbit) | Ki | 67.6281 | 1 | 32 |
| Low-density lipoprotein receptor | Homo sapiens (human) | IC50 | 9.8000 | 1 | 1 |
| Lysine-specific demethylase 4E | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
| Lysine-specific demethylase 4E | Homo sapiens (human) | Ki | 4.3300 | 1 | 1 |
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | IC50 | 10.6322 | 5 | 9 |
| Lysosomal alpha-glucosidase | Homo sapiens (human) | IC50 | 251.3950 | 2 | 2 |
| M-phase inducer phosphatase 1 | Homo sapiens (human) | IC50 | 25.0000 | 1 | 1 |
| Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | IC50 | 0.1122 | 7 | 7 |
| Macrophage colony-stimulating factor 1 receptor | Mus musculus (house mouse) | IC50 | 0.5340 | 1 | 1 |
| Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | Ki | 0.0100 | 1 | 1 |
| Macrophage migration inhibitory factor | Homo sapiens (human) | IC50 | 2.4000 | 1 | 1 |
| Macrophage migration inhibitory factor | Homo sapiens (human) | Ki | 0.5700 | 2 | 2 |
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | IC50 | 2.7900 | 1 | 1 |
| MAP kinase-activated protein kinase 2 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | IC50 | 0.2620 | 1 | 1 |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | IC50 | 1.1090 | 34 | 41 |
| Mcl-1 | Homo sapiens (human) | IC50 | 0.5400 | 1 | 1 |
| Melanocortin receptor 3 | Homo sapiens (human) | IC50 | 19.9340 | 1 | 2 |
| Melanocortin receptor 3 | Homo sapiens (human) | Ki | 17.3965 | 1 | 2 |
| Melanocortin receptor 4 | Homo sapiens (human) | IC50 | 40.8612 | 3 | 4 |
| Melanocortin receptor 4 | Homo sapiens (human) | Ki | 14.0600 | 1 | 2 |
| Melanocortin receptor 5 | Homo sapiens (human) | IC50 | 6.4660 | 1 | 3 |
| Melanocortin receptor 5 | Homo sapiens (human) | Ki | 6.0657 | 1 | 3 |
| Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | Homo sapiens (human) | IC50 | 2.6565 | 2 | 4 |
| Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | Homo sapiens (human) | Ki | 1.3283 | 2 | 4 |
| Menin | Homo sapiens (human) | IC50 | 69.0000 | 1 | 1 |
| Metabotropic glutamate receptor 1 | Rattus norvegicus (Norway rat) | IC50 | 0.0085 | 2 | 2 |
| Methionine aminopeptidase 2 | Homo sapiens (human) | IC50 | 2.4300 | 1 | 1 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | IC50 | 50.0548 | 2 | 2 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | IC50 | 10.0000 | 2 | 2 |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | IC50 | 0.1000 | 3 | 3 |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | IC50 | 0.1000 | 3 | 3 |
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | IC50 | 0.1000 | 3 | 3 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | IC50 | 1.2735 | 12 | 12 |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | IC50 | 2.7670 | 2 | 2 |
| Mitogen-activated protein kinase 8 | Homo sapiens (human) | IC50 | 40.0000 | 3 | 3 |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | IC50 | 10.0000 | 2 | 2 |
| MO15-related protein kinase Pfmrk | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 77.9500 | 1 | 2 |
| Monoglyceride lipase | Homo sapiens (human) | IC50 | 16.6000 | 1 | 1 |
| MPI protein | Homo sapiens (human) | IC50 | 0.2905 | 2 | 2 |
| Mu-type opioid receptor | Homo sapiens (human) | IC50 | 7.3274 | 2 | 5 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.0004 | 1 | 1 |
| Mu-type opioid receptor | Homo sapiens (human) | Ki | 2.4787 | 3 | 6 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.0002 | 1 | 1 |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | IC50 | 14.6500 | 1 | 2 |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | IC50 | 12.7000 | 1 | 1 |
| Multidrug resistance-associated protein 1 | Rattus norvegicus (Norway rat) | Ki | 0.0467 | 3 | 4 |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | IC50 | 3.5082 | 10 | 10 |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | Ki | 5.0000 | 1 | 1 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 109.3375 | 1 | 16 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | IC50 | 0.7874 | 1 | 5 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | IC50 | 1.9120 | 2 | 5 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | Ki | 5.4583 | 3 | 9 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Ki | 0.0603 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | IC50 | 2.1282 | 1 | 6 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | IC50 | 2.2550 | 2 | 4 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | Ki | 2.1258 | 2 | 9 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | Ki | 0.0603 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | IC50 | 1.1928 | 1 | 5 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | IC50 | 2.2550 | 2 | 4 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | Ki | 3.6075 | 2 | 8 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | Ki | 0.0603 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | IC50 | 1.1153 | 1 | 5 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | IC50 | 2.2550 | 2 | 4 |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | Ki | 1.7964 | 3 | 9 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | Ki | 0.0603 | 1 | 1 |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | IC50 | 0.1964 | 1 | 4 |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | IC50 | 2.2550 | 2 | 4 |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | Ki | 6.5632 | 2 | 7 |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | Ki | 0.0603 | 1 | 1 |
| Myelin transcription factor 1 | Homo sapiens (human) | IC50 | 0.0630 | 1 | 1 |
| Myeloblastin | Mus musculus (house mouse) | IC50 | 10.0000 | 1 | 1 |
| Myosin light chain kinase, smooth muscle | Gallus gallus (chicken) | IC50 | 0.2600 | 1 | 1 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | IC50 | 2.3567 | 3 | 3 |
| NADPH oxidase 1 | Homo sapiens (human) | IC50 | 17.0000 | 1 | 3 |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | IC50 | 104.6200 | 5 | 5 |
| neuropeptide Y receptor type 1 | Homo sapiens (human) | IC50 | 35.0000 | 1 | 1 |
| neuropeptide Y receptor type 2 | Homo sapiens (human) | IC50 | 35.0000 | 1 | 1 |
| neutrophil cytosol factor 1 | Homo sapiens (human) | IC50 | 0.3900 | 1 | 1 |
| Neutrophil cytosol factor 1 | Homo sapiens (human) | Ki | 125.0000 | 3 | 3 |
| Neutrophil elastase | Homo sapiens (human) | IC50 | 22.8594 | 3 | 5 |
| Neutrophil elastase | Mus musculus (house mouse) | IC50 | 10.0000 | 1 | 1 |
| NF-kappa-B essential modulator | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Nociceptin receptor | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| Non-structural protein 4A | | Ki | 0.0060 | 1 | 1 |
| NS5 | Zika virus | IC50 | 1.3600 | 1 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | IC50 | 5.7666 | 1 | 2 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | Ki | 4.7244 | 1 | 2 |
| nucleotide-binding oligomerization domain-containing protein 2 isoform 1 | Homo sapiens (human) | IC50 | 11.9570 | 1 | 1 |
| Papain | Carica papaya (papaya) | IC50 | 50.4000 | 2 | 2 |
| Papain | Carica papaya (papaya) | Ki | 52.0000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase A | Homo sapiens (human) | IC50 | 0.0252 | 12 | 12 |
| Peptidyl-prolyl cis-trans isomerase A | Homo sapiens (human) | Ki | 0.0574 | 8 | 9 |
| Peptidyl-prolyl cis-trans isomerase B | Homo sapiens (human) | IC50 | 0.0088 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase D | Homo sapiens (human) | IC50 | 0.0036 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase D | Homo sapiens (human) | Ki | 0.0129 | 4 | 4 |
| Peptidyl-prolyl cis-trans isomerase FKBP14 | Homo sapiens (human) | Ki | 76.2000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | IC50 | 0.5179 | 7 | 7 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Mus musculus (house mouse) | IC50 | 0.0010 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | Ki | 1.4703 | 5 | 6 |
| Peptidyl-prolyl cis-trans isomerase FKBP1B | Homo sapiens (human) | Ki | 0.0060 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP3 | Homo sapiens (human) | Ki | 124.0000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP4 | Homo sapiens (human) | IC50 | 0.0160 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP4 | Homo sapiens (human) | Ki | 24.2000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP5 | Homo sapiens (human) | Ki | 0.0030 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Ki | 200.0000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 | Homo sapiens (human) | Ki | 187.0000 | 1 | 1 |
| Peptidylglycine alpha-amidating monooxygenase | Rattus norvegicus (Norway rat) | Ki | 0.0060 | 1 | 1 |
| perilipin-1 | Homo sapiens (human) | IC50 | 2.2750 | 2 | 2 |
| perilipin-5 | Homo sapiens (human) | IC50 | 1.2280 | 3 | 3 |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | IC50 | 0.0031 | 1 | 6 |
| Phosphatidylinositol 3-kinase regulatory subunit alpha | Homo sapiens (human) | IC50 | 14,700.1894 | 7 | 10 |
| Phosphatidylinositol 3-kinase regulatory subunit alpha | Homo sapiens (human) | Ki | 0.0002 | 3 | 3 |
| Phosphatidylinositol 4-kinase alpha | Homo sapiens (human) | IC50 | 0.2800 | 1 | 1 |
| Phosphatidylinositol 4-kinase beta | Homo sapiens (human) | IC50 | 0.4400 | 1 | 1 |
| Phosphatidylinositol 4-kinase type 2-alpha | Homo sapiens (human) | IC50 | 30.0000 | 1 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | IC50 | 5,072.4472 | 25 | 29 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | Ki | 0.0400 | 3 | 3 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Homo sapiens (human) | IC50 | 9,807.3534 | 11 | 15 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Homo sapiens (human) | Ki | 0.0003 | 2 | 2 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Homo sapiens (human) | IC50 | 9,196.2679 | 11 | 16 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Homo sapiens (human) | Ki | 0.0000 | 2 | 2 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | IC50 | 8,175.8554 | 14 | 18 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Mus musculus (house mouse) | IC50 | 0.5700 | 1 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | Ki | 0.0003 | 2 | 2 |
| Phosphoethanolamine N-methyltransferase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 554.0000 | 1 | 1 |
| phosphoethanolamine/phosphocholine phosphatase isoform 1 | Homo sapiens (human) | IC50 | 0.1110 | 1 | 1 |
| Phosphoinositide 3-kinase regulatory subunit 5 | Homo sapiens (human) | IC50 | 0.0190 | 1 | 1 |
| phosphomannomutase 2 | Homo sapiens (human) | IC50 | 0.6720 | 1 | 1 |
| Pirin | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Plasmepsin V | Plasmodium falciparum 3D7 | IC50 | 20.0000 | 1 | 1 |
| Plasminogen | Rattus norvegicus (Norway rat) | IC50 | 2.6200 | 1 | 1 |
| Platelet glycoprotein VI | Homo sapiens (human) | IC50 | 37.5000 | 2 | 2 |
| Platelet-activating factor receptor | Cavia porcellus (domestic guinea pig) | IC50 | 200.0000 | 1 | 1 |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | IC50 | 6.8217 | 8 | 8 |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | Ki | 0.0100 | 1 | 1 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | IC50 | 7.0821 | 15 | 15 |
| Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | IC50 | 0.1235 | 2 | 8 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | Ki | 0.0100 | 1 | 1 |
| Pleiotropic ABC efflux transporter of multiple drugs | Saccharomyces cerevisiae S288C | IC50 | 7.6800 | 1 | 5 |
| Polycomb protein EED | Homo sapiens (human) | IC50 | 51.3500 | 2 | 2 |
| Polycomb protein EED | Homo sapiens (human) | Ki | 23.0100 | 1 | 1 |
| Polycomb protein SUZ12 | Homo sapiens (human) | IC50 | 8.9000 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | IC50 | 50.4250 | 1 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | IC50 | 10.0000 | 2 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | Ki | 24.2000 | 1 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | IC50 | 31.5320 | 2 | 5 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | Ki | 1.6000 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | IC50 | 33.1800 | 2 | 5 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | IC50 | 16.0550 | 1 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | Ki | 0.6000 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | IC50 | 51.0929 | 3 | 7 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Rattus norvegicus (Norway rat) | IC50 | 0.2600 | 1 | 1 |
| Potassium channel subfamily K member 2 | Homo sapiens (human) | IC50 | 3.7000 | 1 | 2 |
| Potassium voltage-gated channel subfamily D member 3 | Homo sapiens (human) | IC50 | 4,492.8360 | 3 | 3 |
| Potassium voltage-gated channel subfamily E member 1 | Homo sapiens (human) | IC50 | 249.7653 | 3 | 3 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 372.0445 | 37 | 47 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | Ki | 2.1520 | 8 | 11 |
| Potassium voltage-gated channel subfamily KQT member 1 | Homo sapiens (human) | IC50 | 249.7653 | 3 | 3 |
| Probable linoleate 9S-lipoxygenase 5 | Solanum tuberosum (potato) | IC50 | 43.0000 | 1 | 1 |
| Probable maltase-glucoamylase 2 | Homo sapiens (human) | IC50 | 2.7900 | 1 | 1 |
| Procathepsin L | Homo sapiens (human) | IC50 | 6.5630 | 5 | 30 |
| Procathepsin L | Homo sapiens (human) | Ki | 2.9492 | 2 | 7 |
| Progesterone receptor | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Prolyl endopeptidase | Homo sapiens (human) | IC50 | 20.1000 | 2 | 3 |
| Proprotein convertase subtilisin/kexin type 9 | Homo sapiens (human) | IC50 | 9.8000 | 1 | 1 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | IC50 | 8.4215 | 1 | 2 |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | IC50 | 150.0000 | 1 | 1 |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | IC50 | 2.1000 | 1 | 1 |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 1 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | IC50 | 150.0000 | 1 | 1 |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 1 |
| Protease | Human immunodeficiency virus 1 | IC50 | 22.0222 | 6 | 8 |
| Protease | Human immunodeficiency virus 1 | Ki | 0.0005 | 23 | 23 |
| Protein kinase C alpha type | Homo sapiens (human) | IC50 | 12.5022 | 7 | 12 |
| Protein kinase C beta type | Homo sapiens (human) | IC50 | 0.0025 | 5 | 10 |
| Protein kinase C beta type | Mus musculus (house mouse) | IC50 | 0.2340 | 1 | 1 |
| Protein kinase C delta type | Homo sapiens (human) | IC50 | 5.0023 | 5 | 10 |
| Protein kinase C epsilon type | Homo sapiens (human) | IC50 | 0.0040 | 5 | 10 |
| Protein kinase C eta type | Homo sapiens (human) | IC50 | 0.0041 | 4 | 9 |
| Protein kinase C theta type | Homo sapiens (human) | IC50 | 0.0094 | 6 | 11 |
| Protein kinase C zeta type | Homo sapiens (human) | IC50 | 27.7000 | 2 | 2 |
| Protein Mdm4 | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Protein skinhead-1 | Caenorhabditis elegans | IC50 | 100.0000 | 1 | 1 |
| Protein-glutamine gamma-glutamyltransferase 2 | Homo sapiens (human) | IC50 | 65.0000 | 1 | 3 |
| Protein-tyrosine kinase 6 | Homo sapiens (human) | IC50 | 0.0072 | 2 | 2 |
| Prothrombin | Homo sapiens (human) | IC50 | 7.3837 | 5 | 6 |
| Prothrombin | Homo sapiens (human) | Ki | 3.4394 | 1 | 6 |
| Proto-oncogene tyrosine-protein kinase LCK | Mus musculus (house mouse) | IC50 | 0.0004 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase LCK | Mus musculus (house mouse) | Ki | 0.0001 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | GI50 | 0.1013 | 3 | 3 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | IC50 | 1.1583 | 10 | 11 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | GI50 | 0.2352 | 1 | 2 |
| Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | IC50 | 0.1922 | 4 | 5 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | IC50 | 1.3418 | 28 | 37 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | Ki | 0.0002 | 2 | 2 |
| Quinolone resistance protein NorA | Staphylococcus aureus | IC50 | 11.5000 | 1 | 1 |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | IC50 | 32.2500 | 4 | 4 |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| RAD51 | Homo sapiens (human) | IC50 | 85.0000 | 1 | 1 |
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | IC50 | 0.1623 | 32 | 35 |
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | Ki | 0.0060 | 1 | 1 |
| Rapamycin-insensitive companion of mTOR | Homo sapiens (human) | IC50 | 0.0002 | 1 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | IC50 | 9.0816 | 5 | 7 |
| Receptor-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | IC50 | 18.7333 | 3 | 3 |
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | IC50 | 1.2620 | 3 | 3 |
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | Ki | 0.0100 | 1 | 1 |
| receptor-interacting serine/threonine-protein kinase 2 isoform 1 | Homo sapiens (human) | IC50 | 26.4500 | 1 | 2 |
| Receptor-interacting serine/threonine-protein kinase 3 | Homo sapiens (human) | IC50 | 4.9240 | 2 | 3 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | GI50 | 3.1330 | 3 | 3 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | IC50 | 5.8391 | 25 | 25 |
| Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) | IC50 | 41.4000 | 1 | 1 |
| Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) | IC50 | 36.9000 | 1 | 1 |
| Receptor-type tyrosine-protein phosphatase S | Homo sapiens (human) | IC50 | 10.3000 | 1 | 1 |
| Regulatory-associated protein of mTOR | Homo sapiens (human) | IC50 | 0.1500 | 2 | 3 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | IC50 | 14.3249 | 9 | 50 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | Ki | 5.3020 | 5 | 9 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | IC50 | 8.4393 | 3 | 27 |
| Replicase polyprotein 1ab | Human coronavirus 229E | IC50 | 8.8994 | 3 | 33 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 30.4553 | 67 | 163 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | IC50 | 60.6367 | 17 | 81 |
| Replicase polyprotein 1ab | Avian infectious bronchitis virus (strain Beaudette CK) | Ki | 0.0009 | 1 | 12 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | Ki | 1.1337 | 2 | 2 |
| Replicase polyprotein 1ab | Feline infectious peritonitis virus (strain 79-1146) | Ki | 0.0009 | 1 | 12 |
| Replicase polyprotein 1ab | Human coronavirus 229E | Ki | 0.7552 | 3 | 15 |
| Replicase polyprotein 1ab | Human coronavirus HKU1 (isolate N5) | Ki | 0.0009 | 1 | 12 |
| Replicase polyprotein 1ab | Human coronavirus NL63 | Ki | 0.0009 | 1 | 12 |
| Replicase polyprotein 1ab | Human coronavirus OC43 | Ki | 0.0009 | 1 | 12 |
| Replicase polyprotein 1ab | Murine hepatitis virus strain A59 | Ki | 0.0009 | 1 | 12 |
| Replicase polyprotein 1ab | Pipistrellus bat coronavirus HKU5 | Ki | 0.0009 | 1 | 12 |
| Replicase polyprotein 1ab | Porcine epidemic diarrhea virus CV777 | Ki | 0.0009 | 1 | 12 |
| Replicase polyprotein 1ab | Rousettus bat coronavirus HKU9 | Ki | 0.0009 | 1 | 12 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Ki | 2.4423 | 11 | 31 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | Ki | 6.0383 | 11 | 22 |
| Replicase polyprotein 1ab | Tylonycteris bat coronavirus HKU4 | Ki | 0.0009 | 1 | 12 |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | IC50 | 0.4550 | 1 | 1 |
| Rho-associated protein kinase 1 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Rho-associated protein kinase 2 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | IC50 | 1.2270 | 3 | 3 |
| RNA polymerase beta subunit (EC 2.7.7.6), partial | Escherichia coli | IC50 | 11.6872 | 1 | 1 |
| RNA-directed RNA polymerase | | IC50 | 5.6000 | 1 | 1 |
| RuvB-like 1 | Homo sapiens (human) | IC50 | 66.0000 | 1 | 1 |
| RuvB-like 2 | Homo sapiens (human) | IC50 | 66.0000 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | IC50 | 44.2500 | 2 | 4 |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | IC50 | 37.2500 | 2 | 2 |
| Serine hydrolase RBBP9 | Homo sapiens (human) | IC50 | 7.8000 | 1 | 1 |
| Serine protease hepsin | Homo sapiens (human) | IC50 | 0.0235 | 2 | 2 |
| Serine protease hepsin | Homo sapiens (human) | Ki | 3.4394 | 1 | 6 |
| Serine/threonine-protein kinase A-Raf | Homo sapiens (human) | IC50 | 0.0130 | 4 | 4 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | GI50 | 1.0000 | 1 | 1 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | IC50 | 2.6236 | 80 | 85 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | Ki | 0.0327 | 3 | 3 |
| Serine/threonine-protein kinase B-raf | Mus musculus (house mouse) | IC50 | 0.1300 | 1 | 1 |
| Serine/threonine-protein kinase D3 | Homo sapiens (human) | IC50 | 0.0021 | 1 | 1 |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | IC50 | 3.9340 | 24 | 27 |
| Serine/threonine-protein kinase mTOR | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Serine/threonine-protein kinase PAK 2 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | IC50 | 5.0251 | 2 | 2 |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | IC50 | 2.7880 | 5 | 5 |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Ki | 12.1925 | 1 | 8 |
| Serine/threonine-protein kinase PLK2 | Homo sapiens (human) | IC50 | 314.0000 | 1 | 1 |
| Serine/threonine-protein kinase PLK2 | Homo sapiens (human) | Ki | 12.1925 | 1 | 8 |
| Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | IC50 | 10.0792 | 4 | 4 |
| Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | Ki | 12.1925 | 1 | 8 |
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | Ki | 12.1925 | 1 | 8 |
| Serine/threonine-protein kinase SIK1 | Homo sapiens (human) | IC50 | 0.0010 | 1 | 1 |
| Serine/threonine-protein kinase SIK1 | Homo sapiens (human) | Ki | 0.0100 | 1 | 1 |
| Serine/threonine-protein kinase SIK2 | Homo sapiens (human) | IC50 | 0.0030 | 1 | 1 |
| Serine/threonine-protein kinase SIK3 | Homo sapiens (human) | IC50 | 0.0050 | 1 | 1 |
| Serine/threonine-protein kinase TNNI3K | Homo sapiens (human) | IC50 | 0.1750 | 2 | 2 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Homo sapiens (human) | IC50 | 0.1830 | 1 | 1 |
| Sialidase-2 | Homo sapiens (human) | IC50 | 130.0000 | 1 | 1 |
| Sigma intracellular receptor 2 | Homo sapiens (human) | Ki | 0.2824 | 2 | 6 |
| Sigma intracellular receptor 2 | Rattus norvegicus (Norway rat) | Ki | 0.0136 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | IC50 | 0.7394 | 2 | 7 |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | Ki | 0.0004 | 4 | 4 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Ki | 0.3052 | 7 | 16 |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | Ki | 0.0710 | 1 | 1 |
| Signal transducer and activator of transcription 3 | Homo sapiens (human) | IC50 | 1.6867 | 3 | 3 |
| Sodium channel protein type 1 subunit alpha | Homo sapiens (human) | IC50 | 4.3000 | 1 | 1 |
| Sodium channel protein type 10 subunit alpha | Homo sapiens (human) | IC50 | 4.3000 | 1 | 1 |
| Sodium channel protein type 11 subunit alpha | Homo sapiens (human) | IC50 | 4.3000 | 1 | 1 |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | IC50 | 4.3000 | 1 | 1 |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | IC50 | 4.3000 | 1 | 1 |
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | IC50 | 4.3000 | 1 | 1 |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | IC50 | 918.1249 | 8 | 8 |
| Sodium channel protein type 7 subunit alpha | Homo sapiens (human) | IC50 | 4.3000 | 1 | 1 |
| Sodium channel protein type 8 subunit alpha | Homo sapiens (human) | IC50 | 4.3000 | 1 | 1 |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | IC50 | 4.3000 | 1 | 1 |
| Sodium- and chloride-dependent betaine transporter | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 1 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | IC50 | 1.4791 | 1 | 2 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | Ki | 0.0040 | 1 | 1 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | IC50 | 2.2434 | 2 | 5 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | Ki | 1.6765 | 1 | 4 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | IC50 | 1.2883 | 2 | 6 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | Ki | 1.5204 | 1 | 5 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | IC50 | 1.8712 | 3 | 9 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | IC50 | 0.0060 | 2 | 2 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | Ki | 0.6097 | 3 | 8 |
| Sodium/bile acid cotransporter | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | IC50 | 0.2190 | 1 | 3 |
| Solute carrier family 2, facilitated glucose transporter member 4 | Mus musculus (house mouse) | IC50 | 0.0420 | 1 | 1 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | IC50 | 36.5667 | 2 | 6 |
| Solute carrier family 22 member 2 | Homo sapiens (human) | IC50 | 16.5000 | 1 | 1 |
| Solute carrier family 22 member 3 | Homo sapiens (human) | IC50 | 0.5000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | IC50 | 0.8538 | 8 | 8 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | Ki | 0.4845 | 4 | 4 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | IC50 | 0.7600 | 2 | 2 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | Ki | 1.2000 | 1 | 1 |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | IC50 | 37.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | Ki | 36.0000 | 1 | 1 |
| Somatostatin receptor type 2 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| Somatostatin receptor type 3 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| Somatostatin receptor type 4 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| Somatostatin receptor type 5 | Homo sapiens (human) | Ki | 4.0700 | 2 | 2 |
| Sphingomyelin phosphodiesterase | Homo sapiens (human) | IC50 | 11.0000 | 1 | 1 |
| sphingosine 1-phosphate receptor 1 | Homo sapiens (human) | IC50 | 7.1950 | 1 | 1 |
| Sphingosine-1-phosphate receptor 4 | Homo sapiens (human) | IC50 | 1.0570 | 2 | 2 |
| Spike glycoprotein | Betacoronavirus England 1 | IC50 | 8.7663 | 1 | 22 |
| Spike glycoprotein | Severe acute respiratory syndrome coronavirus 2 | IC50 | 3.5800 | 2 | 2 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | IC50 | 8.7663 | 1 | 22 |
| Spike glycoprotein | Betacoronavirus England 1 | Ki | 0.0075 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Ki | 0.0075 | 1 | 1 |
| Squalene monooxygenase | Rattus norvegicus (Norway rat) | IC50 | 0.1300 | 1 | 1 |
| Structural capsid protein | Human immunodeficiency virus 1 | IC50 | 0.0467 | 1 | 1 |
| Substance-K receptor | Cavia porcellus (domestic guinea pig) | IC50 | 100.0000 | 1 | 1 |
| Substance-K receptor | Homo sapiens (human) | IC50 | 14.2010 | 1 | 4 |
| Substance-K receptor | Homo sapiens (human) | Ki | 4.7338 | 1 | 4 |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | IC50 | 100.0000 | 1 | 1 |
| Substance-P receptor | Homo sapiens (human) | IC50 | 15.7930 | 1 | 1 |
| Substance-P receptor | Homo sapiens (human) | Ki | 8.6150 | 1 | 1 |
| Sucrase-isomaltase, intestinal | Homo sapiens (human) | IC50 | 29.9300 | 3 | 3 |
| Sucrase-isomaltase, intestinal | Rattus norvegicus (Norway rat) | IC50 | 156.0000 | 2 | 2 |
| Sulfhydryl oxidase 1 | Homo sapiens (human) | IC50 | 5.4000 | 1 | 1 |
| SUMO-activating enzyme subunit 1 | Homo sapiens (human) | IC50 | 2.2000 | 1 | 1 |
| SUMO-conjugating enzyme UBC9 | Homo sapiens (human) | IC50 | 7.7025 | 4 | 8 |
| SUMO1 activating enzyme subunit 1 | Homo sapiens (human) | IC50 | 7.7025 | 4 | 8 |
| Target of rapamycin complex 2 subunit MAPKAP1 | Homo sapiens (human) | IC50 | 0.0002 | 1 | 1 |
| Target of rapamycin complex subunit LST8 | Homo sapiens (human) | IC50 | 0.1126 | 3 | 4 |
| Testosterone 17-beta-dehydrogenase 3 | Homo sapiens (human) | IC50 | 97.6100 | 2 | 2 |
| TGF-beta receptor type-1 | Homo sapiens (human) | IC50 | 3.7000 | 1 | 1 |
| Thioredoxin glutathione reductase | Schistosoma mansoni | IC50 | 7.0800 | 1 | 1 |
| Toll-like receptor 7 | Homo sapiens (human) | IC50 | 3.4000 | 3 | 3 |
| Toll-like receptor 9 | Homo sapiens (human) | IC50 | 0.1100 | 1 | 1 |
| Toxin B | Clostridioides difficile | IC50 | 0.0172 | 1 | 1 |
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | IC50 | 16.1267 | 2 | 3 |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | IC50 | 11.3900 | 2 | 2 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | Human alphaherpesvirus 1 (Herpes simplex virus type 1) | IC50 | 85.4210 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | Rattus norvegicus (Norway rat) | Ki | 0.9100 | 2 | 2 |
| Transmembrane protease serine 2 | Homo sapiens (human) | IC50 | 8.3859 | 2 | 23 |
| Transmembrane protease serine 2 | Homo sapiens (human) | Ki | 2.9492 | 2 | 7 |
| Transmembrane protease serine 6 | Homo sapiens (human) | IC50 | 0.0180 | 1 | 1 |
| Transmembrane protease serine 6 | Homo sapiens (human) | Ki | 3.4394 | 1 | 6 |
| Transthyretin | Homo sapiens (human) | Ki | 0.0026 | 1 | 1 |
| Trypanothione reductase | Trypanosoma brucei brucei | IC50 | 3.4000 | 1 | 1 |
| Trypanothione reductase | Trypanosoma cruzi | IC50 | 74.7714 | 4 | 7 |
| Trypanothione reductase | Trypanosoma cruzi | Ki | 31.8700 | 6 | 10 |
| Trypsin-1 | Homo sapiens (human) | IC50 | 271.1508 | 4 | 5 |
| Trypsin-2 | Homo sapiens (human) | IC50 | 338.9259 | 3 | 4 |
| Trypsin-3 | Homo sapiens (human) | IC50 | 338.9259 | 3 | 4 |
| Tryptophan 2,3-dioxygenase | Homo sapiens (human) | IC50 | 9.8000 | 1 | 1 |
| tumor necrosis factor | Homo sapiens (human) | IC50 | 8.5695 | 1 | 1 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | GI50 | 0.6808 | 19 | 35 |
| Tyrosine-protein kinase ABL1 | Mus musculus (house mouse) | GI50 | 0.0010 | 1 | 1 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | IC50 | 62.4034 | 74 | 93 |
| Tyrosine-protein kinase ABL1 | Mus musculus (house mouse) | IC50 | 0.2259 | 1 | 1 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | Ki | 0.0005 | 1 | 1 |
| Tyrosine-protein kinase Blk | Homo sapiens (human) | GI50 | 0.6525 | 1 | 2 |
| Tyrosine-protein kinase Blk | Mus musculus (house mouse) | IC50 | 0.0080 | 1 | 1 |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | IC50 | 1.6857 | 6 | 6 |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | Ki | 0.0100 | 1 | 1 |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | IC50 | 0.6303 | 4 | 4 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | IC50 | 3.1277 | 6 | 8 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | Ki | 0.0100 | 1 | 1 |
| Tyrosine-protein kinase HCK | Homo sapiens (human) | GI50 | 2.0695 | 1 | 2 |
| Tyrosine-protein kinase HCK | Homo sapiens (human) | IC50 | 2.7652 | 2 | 4 |
| Tyrosine-protein kinase ITK/TSK | Homo sapiens (human) | IC50 | 0.2280 | 1 | 1 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | IC50 | 7.3000 | 1 | 1 |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | IC50 | 40.0000 | 3 | 3 |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | IC50 | 1.5000 | 1 | 1 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | GI50 | 0.4355 | 1 | 2 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | IC50 | 1.8821 | 16 | 16 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | Ki | 0.0100 | 1 | 1 |
| Tyrosine-protein kinase Lyn | Homo sapiens (human) | IC50 | 8.3607 | 3 | 3 |
| Tyrosine-protein kinase Mer | Homo sapiens (human) | IC50 | 1.3700 | 1 | 1 |
| Tyrosine-protein kinase receptor UFO | Homo sapiens (human) | IC50 | 9.1000 | 1 | 1 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | IC50 | 7.4100 | 2 | 2 |
| Tyrosine-protein kinase Tec | Homo sapiens (human) | IC50 | 0.2970 | 1 | 1 |
| Tyrosine-protein kinase TXK | Homo sapiens (human) | IC50 | 0.0003 | 1 | 1 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | IC50 | 0.3020 | 9 | 11 |
| Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | IC50 | 33.5000 | 1 | 1 |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | IC50 | 20.0983 | 4 | 6 |
| Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | IC50 | 55.7000 | 1 | 1 |
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | IC50 | 15.0467 | 1 | 3 |
| Tyrosine-protein phosphatase non-receptor type 9 | Homo sapiens (human) | IC50 | 59.4000 | 1 | 1 |
| tyrosyl-DNA phosphodiesterase 2 | Homo sapiens (human) | IC50 | 21.9627 | 1 | 3 |
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | IC50 | 43.0667 | 2 | 6 |
| ubiquitin-conjugating enzyme E2 variant 1 isoform a | Homo sapiens (human) | IC50 | 89.2000 | 1 | 2 |
| Ubiquitin-like modifier activating enzyme 2 | Homo sapiens (human) | IC50 | 7.7025 | 4 | 8 |
| ubiquitin-like modifier-activating enzyme 1 | Homo sapiens (human) | IC50 | 89.2000 | 1 | 2 |
| UDP-glucose 4-epimerase | Homo sapiens (human) | IC50 | 0.0140 | 1 | 1 |
| UDP-glucose 6-dehydrogenase | Rattus norvegicus (Norway rat) | Ki | 288.0000 | 1 | 1 |
| UDP-glucose 6-dehydrogenase | Streptococcus pyogenes | Ki | 199.5000 | 2 | 2 |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | IC50 | 211.8333 | 1 | 6 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | IC50 | 160.3000 | 3 | 8 |
| UDP-glucuronosyltransferase 1A1 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A4 | Homo sapiens (human) | IC50 | 211.8333 | 1 | 6 |
| UDP-glucuronosyltransferase 2B10 | Homo sapiens (human) | IC50 | 211.8333 | 1 | 6 |
| UDP-glucuronosyltransferase 2B7 | Homo sapiens (human) | IC50 | 211.8333 | 1 | 6 |
| Urease subunit alpha | Helicobacter pylori 26695 | IC50 | 82.5780 | 5 | 5 |
| Urease subunit alpha | Helicobacter pylori 26695 | Ki | 0.2260 | 1 | 1 |
| Urease subunit beta | Helicobacter pylori 26695 | IC50 | 82.5780 | 5 | 5 |
| Urease subunit beta | Helicobacter pylori 26695 | Ki | 0.2260 | 1 | 1 |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | IC50 | 20.0480 | 5 | 5 |
| Vascular endothelial growth factor receptor 2 | Danio rerio (zebrafish) | IC50 | 2.6000 | 1 | 1 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | IC50 | 1.6241 | 85 | 94 |
| Vascular endothelial growth factor receptor 2 | Mus musculus (house mouse) | IC50 | 0.1129 | 2 | 8 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | Ki | 0.0074 | 3 | 3 |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | IC50 | 2.0994 | 7 | 7 |
| Vascular endothelial growth factor receptor 3 | Mus musculus (house mouse) | IC50 | 0.1269 | 1 | 7 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | IC50 | 524.8780 | 9 | 9 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | IC50 | 142.5600 | 5 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | IC50 | 142.5600 | 5 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | IC50 | 142.5600 | 5 | 5 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | Homo sapiens (human) | IC50 | 13.5000 | 1 | 2 |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | IC50 | 37.4000 | 2 | 2 |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | IC50 | 47.6050 | 2 | 2 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | Escherichia coli K-12 | Kd | 18.0000 | 1 | 1 |
| 26S proteasome regulatory subunit 6B | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| 3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | Homo sapiens (human) | Kd | 22.6316 | 4 | 19 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| 5'-AMP-activated protein kinase subunit gamma-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| 5'-AMP-activated protein kinase subunit gamma-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| AarF domain-containing protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Actin-related protein 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Actin-related protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 13 |
| Activated CDC42 kinase 1 | Homo sapiens (human) | Kd | 18.1418 | 4 | 19 |
| Activin receptor type-1 | Homo sapiens (human) | Kd | 19.5136 | 4 | 18 |
| Activin receptor type-1B | Homo sapiens (human) | Kd | 16.9769 | 4 | 19 |
| Activin receptor type-2A | Homo sapiens (human) | Kd | 7.2029 | 3 | 7 |
| Activin receptor type-2B | Homo sapiens (human) | Kd | 18.1946 | 4 | 18 |
| Acyl-CoA dehydrogenase family member 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Acyl-CoA dehydrogenase family member 11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 10 |
| Adenine phosphoribosyltransferase | Homo sapiens (human) | Kd | 30.0000 | 1 | 8 |
| Adenosine kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| Adenylate kinase 2, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 13 |
| ADP/ATP translocase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| ADP/ATP translocase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Albumin | Homo sapiens (human) | Kd | 54.9541 | 1 | 1 |
| Albumin | Rattus norvegicus (Norway rat) | Kd | 11.7000 | 1 | 1 |
| ALK tyrosine kinase receptor | Homo sapiens (human) | Kd | 16.0000 | 4 | 10 |
| Angiopoietin-1 receptor | Homo sapiens (human) | Kd | 5.1333 | 5 | 9 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | EC50 | 8.4982 | 2 | 67 |
| Ankyrin repeat and protein kinase domain-containing protein 1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| AP2-associated protein kinase 1 | Homo sapiens (human) | Kd | 20.2140 | 5 | 20 |
| ATP-dependent 6-phosphofructokinase, platelet type | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| ATP-dependent RNA helicase DDX1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| ATP-dependent RNA helicase DDX3X | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| ATP-dependent RNA helicase DDX42 | Homo sapiens (human) | Kd | 30.0000 | 1 | 6 |
| ATP-dependent RNA helicase DHX30 | Homo sapiens (human) | Kd | 30.0000 | 1 | 9 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | EC50 | 20.7036 | 9 | 10 |
| Atypical kinase COQ8A, mitochondrial | Homo sapiens (human) | Kd | 20.9836 | 4 | 21 |
| Atypical kinase COQ8B, mitochondrial | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Aurora kinase A | Homo sapiens (human) | Kd | 22.1833 | 4 | 18 |
| Aurora kinase B | Homo sapiens (human) | Kd | 20.6289 | 4 | 18 |
| Aurora kinase C | Homo sapiens (human) | Kd | 5.8043 | 3 | 7 |
| bcl-2-like protein 11 isoform 1 | Homo sapiens (human) | EC50 | 156.2733 | 1 | 3 |
| BDNF/NT-3 growth factors receptor | Homo sapiens (human) | Kd | 5.2557 | 3 | 7 |
| Beta-adrenergic receptor kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| BMP-2-inducible protein kinase | Homo sapiens (human) | Kd | 21.1381 | 4 | 19 |
| Bone morphogenetic protein receptor type-1A | Homo sapiens (human) | Kd | 21.3530 | 4 | 20 |
| Bone morphogenetic protein receptor type-1B | Homo sapiens (human) | Kd | 21.2551 | 3 | 16 |
| Bone morphogenetic protein receptor type-2 | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| Breakpoint cluster region protein | Homo sapiens (human) | EC50 | 2.7725 | 4 | 4 |
| Breakpoint cluster region protein | Homo sapiens (human) | Kd | 21.8793 | 1 | 11 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | EC50 | 1.7500 | 1 | 1 |
| Calcium-dependent protein kinase 1 | Plasmodium falciparum K1 | EC50 | 0.0680 | 1 | 1 |
| Calcium-dependent protein kinase 1 | Plasmodium falciparum 3D7 | Kd | 2.9125 | 1 | 4 |
| Calcium/calmodulin-dependent protein kinase kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Calcium/calmodulin-dependent protein kinase kinase 2 | Homo sapiens (human) | Kd | 23.3333 | 4 | 21 |
| Calcium/calmodulin-dependent protein kinase type 1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Calcium/calmodulin-dependent protein kinase type 1D | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Calcium/calmodulin-dependent protein kinase type 1G | Homo sapiens (human) | Kd | 12.8571 | 3 | 7 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | Homo sapiens (human) | Kd | 22.6316 | 4 | 19 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma | Homo sapiens (human) | Kd | 21.5789 | 5 | 19 |
| Calcium/calmodulin-dependent protein kinase type IV | Homo sapiens (human) | Kd | 20.6819 | 4 | 18 |
| Calmodulin | Bos taurus (cattle) | Kd | 18.8667 | 1 | 3 |
| Calmodulin-1 | Homo sapiens (human) | Kd | 1.2400 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | Kd | 23.3333 | 3 | 18 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | Kd | 20.6231 | 4 | 18 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 9 |
| cAMP-dependent protein kinase catalytic subunit PRKX | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| cAMP-dependent protein kinase type II-alpha regulatory subunit | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Casein kinase I isoform alpha | Homo sapiens (human) | Kd | 24.1176 | 3 | 17 |
| Casein kinase I isoform alpha-like | Homo sapiens (human) | Kd | 10.0000 | 2 | 6 |
| Casein kinase I isoform delta | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| Casein kinase I isoform epsilon | Homo sapiens (human) | Kd | 20.2893 | 4 | 19 |
| Casein kinase I isoform gamma-1 | Homo sapiens (human) | Kd | 22.6316 | 4 | 19 |
| Casein kinase I isoform gamma-2 | Homo sapiens (human) | Kd | 21.2500 | 4 | 16 |
| Casein kinase I isoform gamma-3 | Homo sapiens (human) | Kd | 23.0000 | 4 | 20 |
| Casein kinase II subunit alpha | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | Kd | 20.7115 | 4 | 18 |
| Cell division control protein 2 homolog | Plasmodium falciparum 3D7 | Kd | 10.0000 | 1 | 4 |
| Cell division cycle 7-related protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 9 |
| cGMP-dependent protein kinase 1 | Homo sapiens (human) | Kd | 22.6316 | 4 | 19 |
| cGMP-dependent protein kinase 2 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Chain A, BCL-2-RELATED PROTEIN A1 | Homo sapiens (human) | EC50 | 156.2733 | 1 | 3 |
| Chain A, Mitogen-activated protein kinase 14 | Homo sapiens (human) | Kd | 0.0914 | 1 | 7 |
| Chain A, protease | Human immunodeficiency virus 1 | Kd | 0.0000 | 1 | 5 |
| Chain B, protease | Human immunodeficiency virus 1 | Kd | 0.0000 | 1 | 5 |
| Choline-phosphate cytidylyltransferase A | Homo sapiens (human) | Kd | 30.0000 | 1 | 6 |
| Chromodomain-helicase-DNA-binding protein 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| citrate synthase 2, partial | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 300.0000 | 1 | 2 |
| Citron Rho-interacting kinase | Homo sapiens (human) | Kd | 22.0316 | 4 | 19 |
| Cyclin-C | Homo sapiens (human) | Kd | 0.3100 | 1 | 1 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | Kd | 27.5303 | 1 | 12 |
| Cyclin-dependent kinase 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 5 |
| Cyclin-dependent kinase 11A | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Cyclin-dependent kinase 11B | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Cyclin-dependent kinase 12 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Cyclin-dependent kinase 13 | Homo sapiens (human) | Kd | 24.6667 | 2 | 15 |
| Cyclin-dependent kinase 14 | Homo sapiens (human) | Kd | 6.9571 | 3 | 7 |
| Cyclin-dependent kinase 15 | Homo sapiens (human) | Kd | 7.1600 | 2 | 5 |
| Cyclin-dependent kinase 16 | Homo sapiens (human) | Kd | 20.5563 | 4 | 18 |
| Cyclin-dependent kinase 17 | Homo sapiens (human) | Kd | 19.1576 | 4 | 18 |
| Cyclin-dependent kinase 18 | Homo sapiens (human) | Kd | 17.2727 | 4 | 11 |
| Cyclin-dependent kinase 19 | Homo sapiens (human) | Kd | 5.8214 | 3 | 7 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | Kd | 20.4844 | 4 | 18 |
| Cyclin-dependent kinase 3 | Homo sapiens (human) | Kd | 21.8778 | 4 | 18 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | Kd | 21.3694 | 3 | 22 |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | Kd | 27.3016 | 1 | 11 |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | Kd | 20.5789 | 4 | 18 |
| Cyclin-dependent kinase 8 | Homo sapiens (human) | Kd | 5.1550 | 4 | 8 |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| Cyclin-dependent kinase-like 1 | Homo sapiens (human) | Kd | 10.0000 | 1 | 4 |
| Cyclin-dependent kinase-like 2 | Homo sapiens (human) | Kd | 6.0520 | 2 | 5 |
| Cyclin-dependent kinase-like 3 | Homo sapiens (human) | Kd | 6.1960 | 2 | 5 |
| Cyclin-dependent kinase-like 5 | Homo sapiens (human) | Kd | 22.8571 | 3 | 14 |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | Kd | 19.7667 | 5 | 19 |
| Cyclin-G-associated kinase | Homo sapiens (human) | Kd | 16.6799 | 6 | 21 |
| Cysteine--tRNA ligase, cytoplasmic | Homo sapiens (human) | Kd | 30.0000 | 1 | 9 |
| Cytochrome c1, heme protein, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Cytochrome P450 1A2 | Homo sapiens (human) | EC50 | 2.0000 | 1 | 1 |
| Cytochrome P450 2D6 | Homo sapiens (human) | EC50 | 2.0000 | 1 | 1 |
| Cytochrome P450 3A4 | Homo sapiens (human) | Kd | 0.0130 | 1 | 1 |
| Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (human) | Kd | 7.1433 | 3 | 7 |
| dCTP pyrophosphatase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Death-associated protein kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Death-associated protein kinase 2 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Death-associated protein kinase 3 | Homo sapiens (human) | Kd | 10.0000 | 4 | 9 |
| Delta-type opioid receptor | Homo sapiens (human) | EC50 | 0.1560 | 1 | 1 |
| Delta-type opioid receptor | Mus musculus (house mouse) | EC50 | 0.0030 | 1 | 2 |
| Delta(24)-sterol reductase | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| Deoxycytidine kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 13 |
| Dihydroorotate dehydrogenase (quinone), mitochondrial | Homo sapiens (human) | EC50 | 0.0550 | 1 | 1 |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | Kd | 10.1977 | 8 | 26 |
| DNA replication licensing factor MCM4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 10 |
| DNA topoisomerase 2-beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| DnaJ homolog subfamily A member 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Dual serine/threonine and tyrosine protein kinase | Homo sapiens (human) | Kd | 10.0000 | 1 | 4 |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | Kd | 15.6200 | 6 | 20 |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | Kd | 14.3911 | 6 | 20 |
| Dual specificity mitogen-activated protein kinase kinase 3 | Homo sapiens (human) | Kd | 22.6316 | 4 | 19 |
| Dual specificity mitogen-activated protein kinase kinase 4 | Homo sapiens (human) | Kd | 17.2727 | 4 | 11 |
| Dual specificity mitogen-activated protein kinase kinase 5 | Homo sapiens (human) | Kd | 18.9406 | 2 | 15 |
| Dual specificity mitogen-activated protein kinase kinase 6 | Homo sapiens (human) | Kd | 22.6316 | 4 | 19 |
| Dual specificity mitogen-activated protein kinase kinase 7 | Homo sapiens (human) | Kd | 10.0000 | 1 | 4 |
| Dual specificity protein kinase CLK1 | Homo sapiens (human) | Kd | 20.6158 | 5 | 19 |
| Dual specificity protein kinase CLK2 | Homo sapiens (human) | Kd | 18.6747 | 4 | 15 |
| Dual specificity protein kinase CLK3 | Homo sapiens (human) | Kd | 20.6667 | 4 | 15 |
| Dual specificity protein kinase CLK4 | Homo sapiens (human) | Kd | 21.0688 | 4 | 16 |
| Dual specificity protein kinase TTK | Homo sapiens (human) | Kd | 20.6176 | 4 | 17 |
| Dual specificity testis-specific protein kinase 1 | Homo sapiens (human) | Kd | 20.0069 | 4 | 19 |
| Dual specificity testis-specific protein kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 8 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | Kd | 24.1176 | 3 | 17 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Homo sapiens (human) | Kd | 17.2727 | 4 | 11 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Dynamin-like 120 kDa protein, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | Kd | 0.1500 | 1 | 1 |
| eIF-2-alpha kinase GCN2 | Homo sapiens (human) | Kd | 7.6000 | 3 | 7 |
| EKC/KEOPS complex subunit TP53RK | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| Electron transfer flavoprotein subunit beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 8 |
| electroneutral potassium-chloride cotransporter KCC2 | Homo sapiens (human) | EC50 | 29.0000 | 1 | 1 |
| Elongation factor Tu, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| endoribonuclease toxin MazF | Escherichia coli str. K-12 substr. MG1655 | EC50 | 99.0000 | 2 | 2 |
| Envelope glycoprotein | Ebola virus - Mayinga, Zaire, 1976 | Kd | 118.0000 | 1 | 1 |
| Ephrin type-A receptor 1 | Homo sapiens (human) | Kd | 12.5393 | 4 | 16 |
| Ephrin type-A receptor 2 | Homo sapiens (human) | Kd | 12.7519 | 6 | 23 |
| Ephrin type-A receptor 3 | Homo sapiens (human) | Kd | 2.7763 | 4 | 8 |
| Ephrin type-A receptor 4 | Homo sapiens (human) | Kd | 16.0778 | 5 | 20 |
| Ephrin type-A receptor 5 | Homo sapiens (human) | Kd | 16.1193 | 6 | 21 |
| Ephrin type-A receptor 6 | Homo sapiens (human) | Kd | 2.7033 | 5 | 9 |
| Ephrin type-A receptor 7 | Homo sapiens (human) | Kd | 18.8021 | 6 | 19 |
| Ephrin type-A receptor 8 | Homo sapiens (human) | Kd | 2.1286 | 5 | 9 |
| Ephrin type-B receptor 1 | Homo sapiens (human) | Kd | 2.7501 | 4 | 8 |
| Ephrin type-B receptor 2 | Homo sapiens (human) | Kd | 16.4311 | 4 | 18 |
| Ephrin type-B receptor 3 | Homo sapiens (human) | Kd | 20.0521 | 4 | 20 |
| Ephrin type-B receptor 4 | Homo sapiens (human) | Kd | 16.1956 | 5 | 20 |
| Ephrin type-B receptor 6 | Homo sapiens (human) | Kd | 15.9393 | 3 | 16 |
| Epidermal growth factor receptor | Homo sapiens (human) | Kd | 9.1727 | 29 | 85 |
| Epithelial discoidin domain-containing receptor 1 | Homo sapiens (human) | Kd | 12.8104 | 5 | 20 |
| Estrogen receptor | Rattus norvegicus (Norway rat) | EC50 | 85.1908 | 1 | 8 |
| Estrogen receptor beta | Rattus norvegicus (Norway rat) | EC50 | 85.1908 | 1 | 8 |
| Eukaryotic peptide chain release factor GTP-binding subunit ERF3B | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Eukaryotic translation initiation factor 2-alpha kinase 1 | Homo sapiens (human) | Kd | 23.5852 | 2 | 17 |
| Eukaryotic translation initiation factor 4E | Homo sapiens (human) | Kd | 0.0005 | 1 | 1 |
| Eukaryotic translation initiation factor 5B | Homo sapiens (human) | Kd | 30.0000 | 1 | 9 |
| Exosome RNA helicase MTR4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Ferrochelatase, mitochondrial | Homo sapiens (human) | Kd | 25.8337 | 2 | 13 |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | Kd | 20.3952 | 5 | 21 |
| Fibroblast growth factor receptor 2 | Homo sapiens (human) | Kd | 4.4143 | 3 | 7 |
| Fibroblast growth factor receptor 3 | Homo sapiens (human) | Kd | 8.2714 | 6 | 14 |
| Fibroblast growth factor receptor 4 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Focal adhesion kinase 1 | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| G protein-coupled receptor kinase 4 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| G protein-coupled receptor kinase 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 9 |
| G-protein coupled bile acid receptor 1 | Homo sapiens (human) | EC50 | 4.7100 | 1 | 1 |
| G-protein coupled receptor 35 | Homo sapiens (human) | EC50 | 16.5000 | 2 | 2 |
| Gamma-butyrobetaine dioxygenase | Homo sapiens (human) | Kd | 4.1000 | 2 | 2 |
| General transcription and DNA repair factor IIH helicase subunit XPD | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Genome polyprotein | Human enterovirus 71 (strain BRCR) | EC50 | 100.0000 | 1 | 1 |
| Genome polyprotein | Human rhinovirus sp. | EC50 | 0.0300 | 1 | 1 |
| Glycine receptor subunit alpha-1 | Homo sapiens (human) | EC50 | 4.2000 | 1 | 1 |
| Glycine--tRNA ligase | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| Glycogen phosphorylase, brain form | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Glycogen phosphorylase, liver form | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | Kd | 21.5600 | 4 | 20 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | Kd | 21.0899 | 4 | 19 |
| glycogen synthase kinase-3 beta isoform 1 | Homo sapiens (human) | EC50 | 300.0000 | 1 | 5 |
| GTP-binding nuclear protein Ran | Homo sapiens (human) | Kd | 30.0000 | 1 | 13 |
| Guanine nucleotide-binding protein G(i) subunit alpha-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 7 |
| heat shock protein 90 | Candida albicans | EC50 | 1.4810 | 1 | 1 |
| Heme oxygenase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| Heparanase | Homo sapiens (human) | Kd | 1,000.0000 | 1 | 1 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | Kd | 16.3568 | 8 | 27 |
| hexokinase HKDC1 | Homo sapiens (human) | EC50 | 38.8000 | 1 | 1 |
| hexokinase-1 isoform HKI | Homo sapiens (human) | EC50 | 41.9000 | 1 | 1 |
| High affinity nerve growth factor receptor | Homo sapiens (human) | Kd | 20.1389 | 5 | 18 |
| HLA class I histocompatibility antigen, A alpha chain | Homo sapiens (human) | Kd | 2.5000 | 1 | 1 |
| Homeodomain-interacting protein kinase 1 | Homo sapiens (human) | Kd | 6.8800 | 2 | 5 |
| Homeodomain-interacting protein kinase 2 | Homo sapiens (human) | Kd | 6.6800 | 2 | 5 |
| Homeodomain-interacting protein kinase 3 | Homo sapiens (human) | Kd | 6.1660 | 2 | 5 |
| Homeodomain-interacting protein kinase 4 | Homo sapiens (human) | Kd | 6.0012 | 2 | 5 |
| Hormonally up-regulated neu tumor-associated kinase | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Hsf1 protein | Mus musculus (house mouse) | EC50 | 1.6420 | 1 | 2 |
| Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | Homo sapiens (human) | Kd | 22.6316 | 4 | 19 |
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Insulin receptor | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| Insulin receptor-related protein | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Insulin-like growth factor 1 receptor | Homo sapiens (human) | Kd | 23.3333 | 4 | 21 |
| Integrin-linked protein kinase | Homo sapiens (human) | Kd | 27.0020 | 1 | 10 |
| Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Interleukin-1 receptor-associated kinase 1 | Homo sapiens (human) | Kd | 21.9727 | 3 | 16 |
| Interleukin-1 receptor-associated kinase 3 | Homo sapiens (human) | Kd | 21.2123 | 4 | 19 |
| Interleukin-1 receptor-associated kinase 4 | Homo sapiens (human) | Kd | 25.0000 | 2 | 16 |
| Isoleucine--tRNA ligase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| LAP4 | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 22.4600 | 2 | 2 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 8 |
| Leukocyte tyrosine kinase receptor | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Leukotriene C4 synthase | Cavia porcellus (domestic guinea pig) | Kd | 10.0000 | 1 | 4 |
| LIM domain kinase 1 | Homo sapiens (human) | Kd | 16.4653 | 5 | 20 |
| LIM domain kinase 2 | Homo sapiens (human) | Kd | 18.4642 | 4 | 19 |
| Long-chain-fatty-acid--CoA ligase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 7 |
| Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | Kd | 1.1287 | 4 | 9 |
| Macrophage-stimulating protein receptor | Homo sapiens (human) | Kd | 23.7500 | 3 | 16 |
| Major prion protein | Homo sapiens (human) | EC50 | 4.6667 | 1 | 3 |
| Major prion protein | Mus musculus (house mouse) | EC50 | 2.0000 | 1 | 1 |
| MAP kinase-activated protein kinase 2 | Homo sapiens (human) | Kd | 20.5854 | 4 | 18 |
| MAP kinase-activated protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| MAP kinase-activated protein kinase 5 | Homo sapiens (human) | Kd | 21.7647 | 4 | 17 |
| MAP kinase-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | Kd | 5.8129 | 3 | 7 |
| MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | Kd | 5.0800 | 4 | 8 |
| MAP/microtubule affinity-regulating kinase 3 | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (human) | Kd | 23.0000 | 4 | 20 |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | EC50 | 0.9429 | 1 | 1 |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | Kd | 2.1269 | 26 | 69 |
| Maternal embryonic leucine zipper kinase | Homo sapiens (human) | Kd | 21.1482 | 4 | 19 |
| Megakaryocyte-associated tyrosine-protein kinase | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| melanocortin receptor 4 | Homo sapiens (human) | EC50 | 50.0000 | 1 | 1 |
| Membrane-associated progesterone receptor component 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 7 |
| Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | Homo sapiens (human) | Kd | 17.7227 | 5 | 20 |
| MEP2 | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 50.5200 | 1 | 1 |
| Microtubule-associated serine/threonine-protein kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Midasin | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Misshapen-like kinase 1 | Homo sapiens (human) | Kd | 18.7120 | 3 | 15 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | Kd | 23.0000 | 4 | 20 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | Kd | 22.2105 | 4 | 19 |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | Kd | 16.4614 | 6 | 21 |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | Kd | 9.0875 | 4 | 8 |
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | Kd | 8.6400 | 2 | 5 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | EC50 | 2.5350 | 2 | 2 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | Kd | 11.4395 | 10 | 25 |
| Mitogen-activated protein kinase 15 | Homo sapiens (human) | Kd | 21.5069 | 4 | 20 |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | Kd | 22.6316 | 4 | 19 |
| Mitogen-activated protein kinase 4 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Mitogen-activated protein kinase 6 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Mitogen-activated protein kinase 7 | Homo sapiens (human) | Kd | 21.7647 | 4 | 17 |
| Mitogen-activated protein kinase 8 | Homo sapiens (human) | Kd | 21.6917 | 4 | 18 |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | Kd | 21.3400 | 5 | 20 |
| Mitogen-activated protein kinase kinase kinase 1 | Homo sapiens (human) | Kd | 20.3154 | 3 | 16 |
| Mitogen-activated protein kinase kinase kinase 10 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Mitogen-activated protein kinase kinase kinase 11 | Homo sapiens (human) | Kd | 20.6117 | 4 | 18 |
| Mitogen-activated protein kinase kinase kinase 12 | Homo sapiens (human) | Kd | 10.0000 | 1 | 4 |
| Mitogen-activated protein kinase kinase kinase 13 | Homo sapiens (human) | Kd | 9.0600 | 2 | 5 |
| Mitogen-activated protein kinase kinase kinase 15 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Mitogen-activated protein kinase kinase kinase 19 | Homo sapiens (human) | Kd | 4.0554 | 2 | 5 |
| Mitogen-activated protein kinase kinase kinase 2 | Homo sapiens (human) | Kd | 22.3467 | 3 | 18 |
| Mitogen-activated protein kinase kinase kinase 20 | Homo sapiens (human) | Kd | 11.8572 | 4 | 19 |
| Mitogen-activated protein kinase kinase kinase 3 | Homo sapiens (human) | Kd | 23.5459 | 3 | 17 |
| Mitogen-activated protein kinase kinase kinase 4 | Homo sapiens (human) | Kd | 21.6116 | 4 | 19 |
| Mitogen-activated protein kinase kinase kinase 5 | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| Mitogen-activated protein kinase kinase kinase 6 | Homo sapiens (human) | Kd | 24.1176 | 3 | 17 |
| Mitogen-activated protein kinase kinase kinase 7 | Homo sapiens (human) | Kd | 3.8543 | 4 | 7 |
| Mitogen-activated protein kinase kinase kinase 9 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Mitogen-activated protein kinase kinase kinase kinase 1 | Homo sapiens (human) | Kd | 19.4617 | 4 | 19 |
| Mitogen-activated protein kinase kinase kinase kinase 2 | Homo sapiens (human) | Kd | 21.9429 | 3 | 17 |
| Mitogen-activated protein kinase kinase kinase kinase 3 | Homo sapiens (human) | Kd | 20.6700 | 4 | 20 |
| Mitogen-activated protein kinase kinase kinase kinase 4 | Homo sapiens (human) | Kd | 16.6933 | 4 | 19 |
| Mitogen-activated protein kinase kinase kinase kinase 5 | Homo sapiens (human) | Kd | 18.8470 | 5 | 22 |
| Mitotic checkpoint serine/threonine-protein kinase BUB1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | EC50 | 0.0580 | 1 | 1 |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | EC50 | 1.7000 | 1 | 1 |
| Multifunctional protein ADE2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| Muscle, skeletal receptor tyrosine-protein kinase | Homo sapiens (human) | Kd | 5.7700 | 3 | 7 |
| Myosin light chain kinase 2, skeletal/cardiac muscle | Homo sapiens (human) | Kd | 7.5250 | 4 | 8 |
| Myosin light chain kinase 3 | Homo sapiens (human) | Kd | 24.9750 | 2 | 16 |
| Myosin light chain kinase family member 4 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Myosin light chain kinase, smooth muscle | Gallus gallus (chicken) | Kd | 10.0000 | 1 | 2 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | Kd | 20.5036 | 5 | 20 |
| Myosin-10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 10 |
| Myosin-14 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Myosin-IIIa | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Myosin-IIIb | Homo sapiens (human) | Kd | 9.5857 | 3 | 7 |
| Myotonin-protein kinase | Homo sapiens (human) | Kd | 7.5143 | 3 | 7 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Non-receptor tyrosine-protein kinase TNK1 | Homo sapiens (human) | Kd | 17.6469 | 4 | 18 |
| Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | Kd | 17.5353 | 6 | 23 |
| Nonstructural protein 5A | | EC50 | 0.0158 | 1 | 1 |
| NS5 | Zika virus | EC50 | 6.9539 | 3 | 3 |
| NT-3 growth factor receptor | Homo sapiens (human) | Kd | 4.6286 | 3 | 7 |
| NUAK family SNF1-like kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| NUAK family SNF1-like kinase 2 | Homo sapiens (human) | Kd | 21.2500 | 4 | 16 |
| Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | EC50 | 2.7660 | 4 | 4 |
| Nuclear receptor subfamily 4 group A member 2 | Homo sapiens (human) | EC50 | 46.0000 | 4 | 6 |
| Nucleolar GTP-binding protein 1 | Homo sapiens (human) | Kd | 27.8198 | 1 | 10 |
| Nucleoside diphosphate kinase B | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| nucleotide-binding oligomerization domain-containing protein 1 isoform 1 | Homo sapiens (human) | EC50 | 20.0000 | 1 | 1 |
| Obg-like ATPase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 9 |
| PAS domain-containing serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 10 |
| Peptidyl-prolyl cis-trans isomerase A | Homo sapiens (human) | Kd | 0.5277 | 12 | 13 |
| Peptidyl-prolyl cis-trans isomerase B | Homo sapiens (human) | Kd | 0.0054 | 2 | 2 |
| Peptidyl-prolyl cis-trans isomerase D | Homo sapiens (human) | Kd | 0.0215 | 2 | 2 |
| Peptidyl-prolyl cis-trans isomerase F, mitochondrial | Homo sapiens (human) | Kd | 0.0010 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | EC50 | 0.0364 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1B | Homo sapiens (human) | Kd | 0.0002 | 1 | 1 |
| Peripheral plasma membrane protein CASK | Homo sapiens (human) | Kd | 10.0000 | 1 | 4 |
| Peroxisomal acyl-coenzyme A oxidase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 8 |
| Peroxisomal acyl-coenzyme A oxidase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | EC50 | 3.5000 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | EC50 | 17.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | Kd | 110.0000 | 1 | 1 |
| Phenylalanine--tRNA ligase beta subunit | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Phosphatidylethanolamine-binding protein 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 8 |
| Phosphatidylinositol 4-kinase beta | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma | Homo sapiens (human) | Kd | 10.0000 | 1 | 4 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | Kd | 9.8149 | 22 | 54 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Homo sapiens (human) | Kd | 8.3346 | 3 | 6 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Homo sapiens (human) | Kd | 8.3342 | 3 | 6 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | Kd | 8.3358 | 3 | 6 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 9 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | Homo sapiens (human) | Kd | 22.6781 | 2 | 15 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Homo sapiens (human) | Kd | 20.5739 | 4 | 18 |
| Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | EC50 | 0.6802 | 1 | 1 |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | Kd | 1.1670 | 5 | 9 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | Kd | 13.3908 | 7 | 21 |
| Poly [ADP-ribose] polymerase tankyrase-2 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
| Polymerase acidic protein | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | EC50 | 21.2667 | 3 | 3 |
| Polymerase basic protein 2 | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | EC50 | 20.0000 | 2 | 2 |
| Potassium channel subfamily K member 2 | Homo sapiens (human) | EC50 | 4.7000 | 1 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | EC50 | 0.0019 | 1 | 1 |
| Probable ATP-dependent RNA helicase DDX6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Procathepsin L | Homo sapiens (human) | EC50 | 8.3239 | 1 | 66 |
| Programmed cell death protein 4 | Homo sapiens (human) | EC50 | 0.0500 | 1 | 1 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | Kd | 10.0000 | 1 | 4 |
| Protease | Human immunodeficiency virus 1 | EC50 | 1.1600 | 1 | 1 |
| Protease | Human immunodeficiency virus 1 | Kd | 0.0004 | 3 | 3 |
| Proteasome subunit alpha type-6 | Homo sapiens (human) | EC50 | 11.2250 | 1 | 4 |
| Protein cereblon | Homo sapiens (human) | EC50 | 10.0000 | 1 | 1 |
| Protein delta homolog 1 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
| Protein kinase C alpha type | Homo sapiens (human) | Kd | 25.8344 | 2 | 12 |
| Protein kinase C beta type | Homo sapiens (human) | Kd | 27.5020 | 1 | 12 |
| Protein kinase C delta type | Homo sapiens (human) | Kd | 20.5558 | 4 | 18 |
| Protein kinase C epsilon type | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Protein kinase C eta type | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Protein kinase C iota type | Homo sapiens (human) | Kd | 24.6667 | 2 | 15 |
| Protein kinase C theta type | Homo sapiens (human) | Kd | 18.9291 | 4 | 18 |
| Protein kinase C zeta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 10 |
| Protein-tyrosine kinase 2-beta | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| Protein-tyrosine kinase 6 | Homo sapiens (human) | Kd | 16.2253 | 4 | 18 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | Kd | 9.4299 | 12 | 37 |
| Proto-oncogene tyrosine-protein kinase ROS | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | Kd | 0.0074 | 3 | 5 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | Kd | 16.2879 | 6 | 21 |
| Purine nucleoside phosphorylase | Mycobacterium tuberculosis H37Rv | Kd | 79.4328 | 1 | 1 |
| Putative heat shock protein HSP 90-beta 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| Putative nucleoside diphosphate kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Pyridoxal kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 12 |
| Rab-like protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 8 |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | Kd | 2.2471 | 3 | 7 |
| Ras-related C3 botulinum toxin substrate 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Ras-related protein Rab-10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Ras-related protein Rab-27A | Homo sapiens (human) | Kd | 30.0000 | 1 | 13 |
| Ras-related protein Rab-6A | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | Kd | 7.5429 | 3 | 7 |
| Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | Kd | 8.0036 | 2 | 5 |
| Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | Kd | 8.0110 | 2 | 5 |
| Receptor-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | Kd | 15.5710 | 5 | 21 |
| Receptor-interacting serine/threonine-protein kinase 3 | Homo sapiens (human) | Kd | 22.1205 | 1 | 11 |
| Receptor-interacting serine/threonine-protein kinase 4 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | Kd | 8.4638 | 29 | 65 |
| recombinase A | Mycobacterium tuberculosis H37Rv | EC50 | 34.4415 | 2 | 22 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | EC50 | 8.5335 | 2 | 68 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | EC50 | 8.3239 | 1 | 66 |
| Replicase polyprotein 1ab | Human coronavirus 229E | EC50 | 8.5335 | 2 | 68 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | EC50 | 8.2232 | 12 | 85 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | EC50 | 8.1649 | 3 | 73 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Kd | 13.2271 | 5 | 7 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | Kd | 22.0000 | 2 | 3 |
| Rho-associated protein kinase 1 | Homo sapiens (human) | Kd | 23.7500 | 3 | 16 |
| Rho-associated protein kinase 2 | Homo sapiens (human) | Kd | 24.1176 | 3 | 17 |
| Rhodopsin kinase GRK1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Rhodopsin kinase GRK7 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Riboflavin-binding protein | Gallus gallus (chicken) | Kd | 2.1000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | Kd | 18.8000 | 7 | 25 |
| Ribosomal protein S6 kinase alpha-2 | Homo sapiens (human) | Kd | 10.0000 | 6 | 14 |
| Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| Ribosomal protein S6 kinase alpha-4 | Homo sapiens (human) | Kd | 19.2308 | 7 | 26 |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | Kd | 19.2308 | 7 | 26 |
| Ribosomal protein S6 kinase alpha-6 | Homo sapiens (human) | Kd | 17.8489 | 7 | 26 |
| Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | Kd | 23.3333 | 3 | 15 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | Kd | 27.8065 | 1 | 13 |
| RNA cytidine acetyltransferase | Homo sapiens (human) | Kd | 30.0000 | 1 | 13 |
| RNA-directed RNA polymerase | | EC50 | 0.0158 | 1 | 1 |
| RNA-directed RNA polymerase catalytic subunit | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | EC50 | 21.2667 | 3 | 3 |
| RPL19A | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 12.3080 | 2 | 3 |
| RuvB-like 2 | Homo sapiens (human) | Kd | 22.0000 | 1 | 1 |
| S-adenosylmethionine synthase isoform type-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Septin-9 | Homo sapiens (human) | Kd | 30.0000 | 1 | 13 |
| Serine/threonine-protein kinase 10 | Homo sapiens (human) | Kd | 15.2220 | 6 | 20 |
| Serine/threonine-protein kinase 16 | Homo sapiens (human) | Kd | 22.6316 | 4 | 19 |
| Serine/threonine-protein kinase 17A | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase 17B | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase 24 | Homo sapiens (human) | Kd | 21.2500 | 4 | 16 |
| Serine/threonine-protein kinase 25 | Homo sapiens (human) | Kd | 9.0571 | 3 | 7 |
| Serine/threonine-protein kinase 26 | Homo sapiens (human) | Kd | 21.3222 | 4 | 18 |
| Serine/threonine-protein kinase 3 | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| Serine/threonine-protein kinase 32A | Homo sapiens (human) | Kd | 10.0000 | 1 | 4 |
| Serine/threonine-protein kinase 32B | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase 32C | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase 33 | Homo sapiens (human) | Kd | 6.7429 | 3 | 7 |
| Serine/threonine-protein kinase 35 | Homo sapiens (human) | Kd | 8.1540 | 2 | 5 |
| Serine/threonine-protein kinase 36 | Homo sapiens (human) | Kd | 4.6525 | 4 | 8 |
| Serine/threonine-protein kinase 38 | Homo sapiens (human) | Kd | 13.3333 | 3 | 6 |
| Serine/threonine-protein kinase 38-like | Homo sapiens (human) | Kd | 14.4444 | 4 | 9 |
| Serine/threonine-protein kinase 4 | Homo sapiens (human) | Kd | 21.8778 | 4 | 18 |
| Serine/threonine-protein kinase A-Raf | Homo sapiens (human) | Kd | 27.2770 | 1 | 11 |
| Serine/threonine-protein kinase ATR | Homo sapiens (human) | Kd | 30.0000 | 1 | 5 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | EC50 | 0.1776 | 3 | 3 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | Kd | 11.5518 | 8 | 26 |
| Serine/threonine-protein kinase BRSK1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase BRSK2 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| Serine/threonine-protein kinase Chk2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase D1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase D2 | Homo sapiens (human) | Kd | 20.5574 | 4 | 18 |
| Serine/threonine-protein kinase D3 | Homo sapiens (human) | Kd | 20.5622 | 4 | 18 |
| Serine/threonine-protein kinase DCLK1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase DCLK2 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase DCLK3 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase ICK | Homo sapiens (human) | Kd | 21.1921 | 3 | 14 |
| Serine/threonine-protein kinase LATS1 | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| Serine/threonine-protein kinase LATS2 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase MAK | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase MARK1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase MARK2 | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| Serine/threonine-protein kinase MRCK alpha | Homo sapiens (human) | Kd | 21.3333 | 4 | 18 |
| Serine/threonine-protein kinase MRCK beta | Homo sapiens (human) | Kd | 21.3216 | 4 | 19 |
| Serine/threonine-protein kinase MRCK gamma | Homo sapiens (human) | Kd | 20.7294 | 4 | 17 |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | Kd | 7.0289 | 3 | 7 |
| Serine/threonine-protein kinase N1 | Homo sapiens (human) | Kd | 19.6481 | 4 | 19 |
| Serine/threonine-protein kinase N2 | Homo sapiens (human) | Kd | 22.6316 | 4 | 19 |
| Serine/threonine-protein kinase N3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 10 |
| Serine/threonine-protein kinase Nek1 | Homo sapiens (human) | Kd | 21.0777 | 4 | 19 |
| Serine/threonine-protein kinase Nek11 | Homo sapiens (human) | Kd | 7.6175 | 1 | 4 |
| Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | Kd | 22.4474 | 4 | 19 |
| Serine/threonine-protein kinase Nek3 | Homo sapiens (human) | Kd | 24.6667 | 2 | 15 |
| Serine/threonine-protein kinase Nek4 | Homo sapiens (human) | Kd | 10.0000 | 1 | 4 |
| Serine/threonine-protein kinase Nek5 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase Nek6 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase Nek7 | Homo sapiens (human) | Kd | 19.2308 | 4 | 13 |
| Serine/threonine-protein kinase Nek9 | Homo sapiens (human) | Kd | 20.5585 | 4 | 18 |
| Serine/threonine-protein kinase NIM1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase NLK | Homo sapiens (human) | Kd | 17.9277 | 4 | 18 |
| Serine/threonine-protein kinase OSR1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase PAK 1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase PAK 2 | Homo sapiens (human) | Kd | 21.7647 | 4 | 17 |
| Serine/threonine-protein kinase PAK 3 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase PAK 4 | Homo sapiens (human) | Kd | 22.3066 | 4 | 22 |
| Serine/threonine-protein kinase PAK 5 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase PAK 6 | Homo sapiens (human) | Kd | 18.3333 | 4 | 12 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | EC50 | 5.0050 | 2 | 2 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | Kd | 21.0468 | 4 | 18 |
| Serine/threonine-protein kinase pim-2 | Homo sapiens (human) | EC50 | 5.0050 | 2 | 2 |
| Serine/threonine-protein kinase pim-2 | Homo sapiens (human) | Kd | 21.2500 | 4 | 16 |
| Serine/threonine-protein kinase pim-3 | Homo sapiens (human) | EC50 | 5.0050 | 2 | 2 |
| Serine/threonine-protein kinase pim-3 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase PknB | Mycobacterium tuberculosis H37Rv | Kd | 10.0000 | 1 | 4 |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Kd | 21.2500 | 4 | 16 |
| Serine/threonine-protein kinase PLK2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | Kd | 18.8116 | 5 | 19 |
| Serine/threonine-protein kinase PRP4 homolog | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase receptor R3 | Homo sapiens (human) | Kd | 14.0920 | 4 | 10 |
| Serine/threonine-protein kinase RIO1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase RIO2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase RIO3 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase SBK1 | Homo sapiens (human) | Kd | 7.8000 | 1 | 4 |
| Serine/threonine-protein kinase Sgk3 | Homo sapiens (human) | Kd | 10.0000 | 1 | 4 |
| Serine/threonine-protein kinase SIK1 | Homo sapiens (human) | Kd | 7.1440 | 3 | 7 |
| Serine/threonine-protein kinase SIK2 | Homo sapiens (human) | Kd | 16.9523 | 4 | 19 |
| Serine/threonine-protein kinase SIK3 | Homo sapiens (human) | Kd | 17.9394 | 3 | 16 |
| Serine/threonine-protein kinase STK11 | Homo sapiens (human) | Kd | 23.0000 | 4 | 20 |
| Serine/threonine-protein kinase TAO1 | Homo sapiens (human) | Kd | 21.6671 | 4 | 17 |
| Serine/threonine-protein kinase TAO2 | Homo sapiens (human) | Kd | 23.7293 | 2 | 15 |
| Serine/threonine-protein kinase TAO3 | Homo sapiens (human) | Kd | 22.7444 | 3 | 18 |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | Kd | 24.1176 | 3 | 17 |
| Serine/threonine-protein kinase TNNI3K | Homo sapiens (human) | Kd | 1.4377 | 4 | 8 |
| Serine/threonine-protein kinase tousled-like 1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase tousled-like 2 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Serine/threonine-protein kinase ULK1 | Homo sapiens (human) | Kd | 21.8868 | 3 | 16 |
| Serine/threonine-protein kinase ULK2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase ULK3 | Homo sapiens (human) | Kd | 22.1224 | 3 | 17 |
| Serine/threonine-protein kinase VRK2 | Homo sapiens (human) | Kd | 8.3000 | 1 | 4 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | Kd | 21.9658 | 3 | 16 |
| Serine/threonine-protein kinase/endoribonuclease IRE2 | Homo sapiens (human) | Kd | 27.0116 | 1 | 10 |
| short transient receptor potential channel 6 isoform 1 | Mus musculus (house mouse) | EC50 | 50.1200 | 1 | 1 |
| Signal recognition particle receptor subunit alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 9 |
| SNF-related serine/threonine-protein kinase | Homo sapiens (human) | Kd | 10.0000 | 1 | 4 |
| Spike glycoprotein | Betacoronavirus England 1 | EC50 | 8.3239 | 1 | 66 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | EC50 | 8.3239 | 1 | 66 |
| SRSF protein kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| SRSF protein kinase 2 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| SRSF protein kinase 3 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| STE20-like serine/threonine-protein kinase | Homo sapiens (human) | Kd | 17.3654 | 5 | 19 |
| STE20-related kinase adapter protein alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| STE20/SPS1-related proline-alanine-rich protein kinase | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| streptokinase A precursor | Streptococcus pyogenes M1 GAS | EC50 | 40.1381 | 2 | 9 |
| Structural maintenance of chromosomes protein 1A | Homo sapiens (human) | Kd | 27.3059 | 1 | 11 |
| Structural maintenance of chromosomes protein 2 | Homo sapiens (human) | Kd | 27.5174 | 1 | 12 |
| Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Testis-specific serine/threonine-protein kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| TGF-beta receptor type-1 | Homo sapiens (human) | Kd | 17.0928 | 4 | 19 |
| TGF-beta receptor type-2 | Homo sapiens (human) | Kd | 18.2419 | 4 | 18 |
| Thyroid hormone receptor-associated protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 9 |
| TRAF2 and NCK-interacting protein kinase | Homo sapiens (human) | Kd | 16.3653 | 4 | 18 |
| Transient receptor potential cation channel subfamily M member 6 | Homo sapiens (human) | Kd | 10.0000 | 1 | 4 |
| Transmembrane protease serine 2 | Homo sapiens (human) | EC50 | 8.2146 | 2 | 67 |
| Transthyretin | Homo sapiens (human) | Kd | 3.1000 | 1 | 1 |
| Tubulin alpha-1A chain | Rattus norvegicus (Norway rat) | Kd | 5.0275 | 1 | 2 |
| Tyrosine--tRNA ligase, cytoplasmic | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | EC50 | 2.7725 | 4 | 4 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | Kd | 3.6687 | 45 | 120 |
| Tyrosine-protein kinase ABL2 | Homo sapiens (human) | Kd | 13.0359 | 5 | 20 |
| Tyrosine-protein kinase Blk | Homo sapiens (human) | Kd | 5.7858 | 3 | 7 |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | Kd | 18.3423 | 4 | 18 |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | Kd | 18.1962 | 4 | 19 |
| Tyrosine-protein kinase Fer | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| Tyrosine-protein kinase Fes/Fps | Homo sapiens (human) | Kd | 22.2222 | 4 | 18 |
| Tyrosine-protein kinase Fgr | Homo sapiens (human) | Kd | 11.4736 | 4 | 14 |
| Tyrosine-protein kinase FRK | Homo sapiens (human) | Kd | 10.2981 | 7 | 22 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | Kd | 15.5461 | 5 | 20 |
| Tyrosine-protein kinase HCK | Homo sapiens (human) | Kd | 15.5925 | 4 | 18 |
| Tyrosine-protein kinase ITK/TSK | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | Kd | 19.5652 | 6 | 23 |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | Kd | 14.6019 | 4 | 12 |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | Kd | 8.2771 | 3 | 7 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | Kd | 13.9919 | 5 | 19 |
| Tyrosine-protein kinase Lyn | Homo sapiens (human) | Kd | 13.7991 | 4 | 19 |
| Tyrosine-protein kinase Mer | Homo sapiens (human) | Kd | 17.7538 | 4 | 13 |
| Tyrosine-protein kinase receptor Tie-1 | Homo sapiens (human) | Kd | 4.4577 | 3 | 7 |
| Tyrosine-protein kinase receptor TYRO3 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Tyrosine-protein kinase receptor UFO | Homo sapiens (human) | Kd | 7.6429 | 3 | 7 |
| Tyrosine-protein kinase Srms | Homo sapiens (human) | Kd | 7.0609 | 3 | 7 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | Kd | 19.9031 | 4 | 18 |
| Tyrosine-protein kinase Tec | Homo sapiens (human) | Kd | 19.4483 | 4 | 18 |
| Tyrosine-protein kinase TXK | Homo sapiens (human) | Kd | 7.1435 | 3 | 7 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | Kd | 15.6931 | 4 | 18 |
| Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| U5 small nuclear ribonucleoprotein 200 kDa helicase | Homo sapiens (human) | Kd | 30.0000 | 1 | 11 |
| UMP-CMP kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 9 |
| Uncharacterized aarF domain-containing protein kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 7 |
| Uncharacterized protein FLJ45252 | Homo sapiens (human) | Kd | 27.3461 | 1 | 11 |
| Uncharacterized serine/threonine-protein kinase SBK3 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | Kd | 3.7655 | 4 | 8 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | EC50 | 0.5000 | 1 | 1 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | Kd | 3.3296 | 6 | 10 |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | Kd | 4.4797 | 5 | 9 |
| Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 13 |
| Wee1-like protein kinase | Homo sapiens (human) | Kd | 20.2156 | 5 | 20 |
| Wee1-like protein kinase 2 | Homo sapiens (human) | Kd | 6.7802 | 3 | 6 |